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Abstract 
Cytokines are a heterogeneous group of polypeptide mediators that have been 
associated with cell-to-cell communication. During development, cytokines may act 
as direct intercellular signals by regulating proliferation and/or differentiation of 
competent target cells or as indirect signals by inducing the expression ofacascade of 
other genes which in their tum affect specific developmental events. However, the 
function of cytokines in embryogenesis still remains largely circumstantial and 
unexplored. In order to determine the in vivo embryonic role of cytokines, the first 
step is to determine when they are expressed during the life cycle ofthe mouse. 
In the first part of the thesis, the expression patterns of 30 cytokines and 
cytokine receptors during mid- to late-gestation (7.5 to 17.5 d.p.c.) of ICR mouse 
were investigated using Reverse Transcription Polymerase Chain Reaction (RT-PCR). 
This method allows the detection and semi-quantitative assessment of changes in the 
mRNA level ofvarious genes at different stages of development. The results revealed 
that more than halfofthe investigated cytokines and cytokine receptors had regulatory 
patterns among the 5 developmental stages, underlying certain biological functions in 
regulating proper embryonic development. However, most cytokines which were well 
documented to be important in adult hematopoiesis, like GM-CSF, G-CSF, IL-3 and 
IL-6, were absent from those embryonic tissues studied in this project. This 
observation indicates that the subset of cytokines controlling hematopoiesis in adult is 
different from those functioning in embryo. The absence of a number of seemingly 
essential cytokines in developing embryos proposed a hypothesis that there might be 
other not yet discovered cytokines specially functioning in embryos. Nevertheless, 
further investigation is required to support this hypothesis. 
In the second part of the study, our focus tumed to a novel cytokine, 
Oncostatin M (OSM), which belongs to the growing neuropoietic family. OSM, like 
II 
LIF and CNTF, was demonstrated to inhibit differentiation of pluripotential 
embryonic stem cells. This property implicates its role in development. Human OSM 
gene has already been cloned and sequenced for a long time but, interestingly, the 
mouse counterpart was not studied at the commencement of the present project. 
Therefore, a preliminary molecular analysis on mouse OSM gene was carried out to 
check the feasibility of using the coding region of human OSM gene as probe to 
isolate OSM gene from the mouse genome. 
An OSM homologue was detected in mouse genome using hOSM exon 2 
fragment as probe, however, the signal was very weak. Using hOSM exon 3 fragment 
as probe, on the other hand, resulted into smearing signals. The high G-C content in 
exon 3 coding region probably caused the non-specific binding. These findings 
concluded that isolation of murine OSM by cross-species hybridization was proven to 
be technically difficult. 
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Chapter 1 
Introduction and Background 
1.1 Role of cytokines in mouse embryonic development 
1.1.1 Why mouse model 
Genetic analysis of mammalian development has long been a challenge to 
scientists. However, the progress in mammalian study can never be as rapid as with 
Drosophila and Caenorhabditis (Hogan et al., 1994), not only because of the large 
mammalian genome size and their long generation time but also due to the slow 
development oftheir embryos. 
Of the diversity of mammals，the mouse has the advantages of small size, 
resistance to infection, large litter size and a relatively rapid generation time. The use 
of mice is also favored by the ease of availability and the simple breeding procedures. 
Therefore, the mouse has become firmly established for long time as the primary 
experimental mammal. It is also the organism on which most molecular biology and 
genetic experiments have been based. 
1.1.2 Embryonic development of mouse 
Embryonic development of the mouse begins with fertilization of the egg by the 
sperm. The method for timing pregnancy and the age of embryos used in this thesis 
followed Hogan et al. (1994). It assumes that fertilization takes place around midnight 
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on a 7 pm _ 5 am dark cycle, then at noon on the following day (i.e. the day on which 
the vaginal plug is found) the embryos are aged ‘half-day postcoitum' or ‘0.5 d.p.c.，. 
/ 
By 24 hours after fertilization, the embryo is still at the two-cell stage, and will 
continue to divide slowly without any increase in mass as it moves along the oviduct 
into the uterus for implantation 4.5 days after fertilization. The implanting embryo, 
called blastocyst, generates the first two cell lineages: the trophoectoderm and the inner 
cell mass. Once implantation has been achieved there is a dramatic increase in the 
growth rate ofthe embryo, particularly in the small group of pluripotential cells known 
as the primitive ectoderm, from which the fetus will develop. Between the 5th and 10th 
day after fertilization the basic body plan of the mouse is established. To summarize 
briefly, the mesoderm is formed and divided up into reiterated pairs of somite blocks, 
generating a segmented pattem along the anterior-posterior body axis. The neural plate 
is induced and folds up into the neural tube, and the placodes of the nose, ear, and eyes 
are formed. The neural crest cells start their migration, and the heart and circulatory 
system and limb buds are established. Therefore, it is during this period that many of 
the genes controlling the differentiation and morphogenesis of the adult organs are 
gradually brought into play. 
The gestation period for the mouse embryo is 19-20 days, depending on the 
strain. The timing ofthe different stages is shown in Table 1.1, which is based on the 
development ofF l hybrids between C57BL/6 females and CBA males (adapted from 
Hogan et al., 1994). 
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Table 1.1 Development of the mouse embryo 
Age (days p.c.) Features 
0-1 one-cell egg 
1 two-cell egg 
2 morula, 4-16 cells 
3 morula-blastocyst; trophectoderm formed 
4 free blastocyst without zona 
4.5 implanting blastocyst; primitive ectoderm 
5 egg cylinder 
6 proamniotic cavity in primitive ectoderm 
6.5 embryonic axis determined 
7 early to mid-primitive streak; amnion forming 
7.5 late primitive streak; allantois appearing 
8 1-7 somites; allantois contacts chorion 
8.5 8-12 somites; tuming of embryo 
9 13-20 somites; heart begins to beat 
9.5 21-29 somites; forelimb bud at level of somites 8-12 
10 30-34 somites; hindlimb bud at level of somites 23-28 
10.5 35-39 somites; tail rudiment 
11 40-44 somites; spleen primordium 
11.5 6- to 7-mm length, forefoot plate 
12 7- to 9-mm, hindfoot plate 
13 9- to 10-mm, whisker rudiments 
14 ll-12mm 
15 12-14mm 
16 14-17 mm 
17 17-20mm 
18 19.5-22.5mm 
19 23 -27 mm; birth 
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The development of mammalian embryo requires the coordinated control of 
both cell proliferation and differentiation. The regional specification of cell growth and 
differentiation in early embryo depends on a continuous series of cell-to-cell 
interactions triggering specific developmental decisions. Since cytokines are 
recognized as the central participants in all cellular communication events, precise 
embryogenesis is essentially controlled by complex and finely balanced cytokine 
networks. 
1.1.3 An overview of cytokines 
Cytokines are a heterogeneous group of polypeptide mediators that have been 
associated with intercellular communication. They serve to coordinate all the important 
biological processes during embryonic development and in later life, including cell 
proliferation, differentiation and immune responses. These soluble molecules are 
produced by many cell types in addition to those of the immune system. Most 
cytokines are multifunctional, thus making their nomenclature and classification 
difficult. Nonetheless, the identity and characteristics of individual cytokines were 
gradually clarified as a consequence of the developments in molecular biology. Within 
the last 5 years, there has been an explosion of information on cytokines and cytokine 
receptors. It is expected that an increasing number of related mediators will be 
continuously added to this category. 
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o. Classes of cytokines 
Various terms have been introduced in attempts to order the enormous number 
of acronyms and titles applied to soluble signaling molecules secreted by cells. Thus, 
the terms ‘lymphokine，，‘monokine，，‘cytokine’ and 'interleukin' are widely used, but 
the term ‘cytokine，has emerged as a generic term to denote this group of soluble 
proteins. This term is used in the present thesis and most of the literature. The term 
‘interleukin’ is used in the naming ofspecific cytokines, such as interleukin-2. 
Identification and characterization of the many cytokines now known has 
resulted in a variety of names and classifications. In the following section, the major 
groups of cytokines will be described briefly according to current nomenclature. Since 
most cytokines have more than one function, there is considerable overlap in the 
biological effects and mechanisms of action of cytokines currently placed in different 
groups. 
i) Growth factors 
It has been known for many years that a number of small polypeptides are able 
to promote growth and division of various cell types in tissue culture. These are 
collectively known as growth factors (Clemens, 1991). However, their names may not 
accurately indicate their specificity. In many cases cell differentiation rather than 
proliferation is the main consequence of treating a cell type with a growth factor. 
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Table 1.2 Properties of major growth factors 
Cytokines Principal sources Principal effects Ref. 
Epidermal EGF Many cell types Proliferation of epithelial cells, ^^ '扣此 1992 
growth factor bone resorption 
Platelet- PDGF Megakaryocytes, Chronic inflammation, tissue 议。二:!广 
derived monocytes, others repair and wound healing Kawahara, 92 
growth factor 
Fibroblast FGF Neuroectoderm, Proliferation of neuroectodermal Gospodarowicz, 
growth factor others cells, endothelial cell, fibroblast, 
angiogenic activity 
Insulin-like IGF Liver, neural tissues Growth of cartilage, mammary Hambiin，93 
growth factor gland, stimulation of glucose 
uptake and protein synthesis 
Nerve growth NGF Neural tissue, Differentiation and survival of Hambiin，93 
factor salivary gland neural tissues 
Transforming growth factor (TGF) a and P were originally discovered in certain 
tumors which allow normal cell types to grow into malignant ('transformed') cells 
(Abbas et al., 1991). However, it was an historical accident that linked these two 
factors together, and the names do not imply any structural or functional relationship. 
Indeed, their true physiological roles may be diametrically opposed since TGF-P is a 
growth inhibitor rather than a mitogen for most cell types (Clemens, 1991). 
Chapter 1 Introduction and Background ]_}_ 
Table 1.3 Properties of transforming growth factors (TGFs) 
Cytokines Principal sources Principal effects Ref" 
TGF-a Tumor cells, EGF-like ciemem，93 
keratinocytes, 
macrophages 
TGF-P Macrophages, T cells, Growth inhibition of transformed cells, "^ Tb''"94^ 
chondrocytes anti-inflammation, immunosuppression, ， 
wound healing 
ii) Interleukins 
The term ‘interleukin， was coined in the hope that by numbering these 
mediators (interleukin-1, interleukin-2, etc.), a universal nomenclature could be created. 
This can avoid the use ofa 'function-based' name which could be misleading in terms 
of the overall activity of that molecule. However, the term ‘interleukin’ may prove 
unfortunate since it implies that these mediators only act as signals between leucocytes. 
Although many of them do have this function, most also have functions which bypass 
leucocytes entirely (Roitt et al., 1993). 
Up to now, a total of at least 15 cytokines have been proposed for the 
interleukin designation with official blessing. Generally, one or two new interleukins 
are added to the list each year (Janeway and Travers, 1994). 
\ 
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Table 1.4 Properties of interleukins (ILs) 
(Aggarwal andPocsik, 1992; Kuby, 1994; Janeway and Travers, 1994) 
Cytokines Principal sources Principal effects 
IL-la, IL-ip Macrophages, Activation ofB, T cells, macrophages 
endothelial cells Fever and inflammatory response 
IL-2 T cells T cell proliferation, stimulation of cytokine 
synthesis by T cells, activation of macrophages 
IL-3 T cells Synergistic action in hematopoiesis 
IL-4 T cells B cell activation, Ig E switch 
IL-5 T cells Growth and differentiation of eosinophil 
IL-6 T cells, macrophages Growth and differentiation ofT and B cells, 
acute phase reaction, hematopoiesis 
IL-7 Stromal cells Growth ofpre-B and pre-T cells 
IL-8 Macrophages Chemotactic for neutrophils, T cells 
IL-9 T cells Mast cell enhancing activity 
IL-10 T cells, macrophages Inhibition of cytokine synthesis 
IL-11 Stromal cells, Synergistic action with IL-3 and IL-4 
fibroblast in hematopoiesis 
IL-12 B cells, macrophages Activation of natural killer cells 
IL-13 T cells B cell growth and differentiation, inhibits 
macrophage inflammatory cytokine production 
IL-14 T cells, B cells B cell proliferation 
IL-15 T cells IL-2 like 
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iii) Colony-stimulating factors 
Colony stimulating factors are defined as proteins which stimulate the clonal 
growth ofbone-marrow cells in vitro (Abbas et al., 1991; Clemens, 1991). Although 
only an operational definition, the name colony stimulating factor (CSF) is 
conceptually useful since this group of cytokines function mainly to regulate 
proliferation and differentiation of various types of hematopoietic cell, such as 
granulocytes, macrophages and erythroid cells. There is functional overlap between 
CSFs and some of the interleukins described earlier. For example, IL-3 was formerly 
called multi-CSF because it promotes growth and differentiation of both myeloid and 
erythroid cell precursors. Thus its activities overlap with those of 
granulocyte/macrophage-CSF. 
Table 1.5 Properties of major colony stimulating factors 
(Abbas et aL, 1991; Clemens, 1991; Aggarwal and Pocsik, 1992) 
Cytokines Principal sources Principal effects 
Granulocyte- GM-CSF Macrophage, T cells, Proliferation of granulocyte and 
Macrophage colony endothelial cells, macrophage precursors 
stimulating factor fibroblasts 
Granulocyte colony G-CSF Macrophages Proliferation of granulocyte 
stimulating factor endothelial cells, progenitors 
fibroblasts 
Macrophage colony M-CSF Monocytes Proliferation of macrophage 
stimulating factor endothelial cells, precursors 
fibroblasts 
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iv) Interferons 
Interferons (IFNs) were originally identified as agents produced by virus-
infected cells which can protect cells against further viral infections. Hence, the name 
was derived from viral ‘interference’ (Clemens, 1991). It is now clear, however, that 
IFNs can elicit many other changes in cellular behavior, including effects on cell 
growth and differentiation and modulation of the immune system. The multiple species 
of IFNs are now classified into three groups, a, p and 丫，on the basis of their distinct 
antigenic properties. Whilst there is only one IFN-y and one IFN-P gene, there are at 
least 23 different genetic loci for the a interferons of which 15 correspond to functional 
genes (Hamblin, 1993). 
IFN-a is produced by leucocytes while IFN-P is produced by fibroblasts, in 
response to viral infection and stimulation with natural or synthetic double stranded 
RNAs. They have potent antiviral activity but at higher concentration have 
antiproliferative activity against both normal and tumor cells. They can enhance the 
expression of Class I MHC gene products and enhance natural killer fNTK) cell activity 
and thus playing a role in immunoregulation (Hamblin, 1993). 
IFN-y has potent immunoregulatory effects on a variety of cells including 
activation of macrophages, enhanced production of IgG by B lymphocytes and 
increased expression of Classes I and II MHC gene products. IFN-y counteracts the 
effect ofIL-4 on B cells and thus inhibiting the activity ofT helper cells (Mosmann and 
Coffman, 1989). 
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Table 1.6 Properties of interferons (IFNs) 
(Clemens, 1991; Kuby, 1994; Aggarwal and Pocsik, 1992; Janeway and Travers, 1994) 
Cytokines Principal sources Principal effects 
IFN-a T and B cells, monocytes 
Anti-viral effect, increase MHC Class I 
IFN-p Fibroblasts, endothelial cells expression 
IFN-y T cells, natural killer cell Macrophage activation, increase MHC 
expression, decrease cytokine synthesis 
v) Tumor necrosis factor 
As with many cytokines, the name 'tumor necrosis factors' (TNFs) reflects the 
history ofthese agents, and is misleading because although TNFs can induce regression 
of some tumors, it gives no clue to their many other actions (Clemens, 1991). There are 
two species of TNF, a and p, that show considerable homology in their amino acid 
sequences. The major cellular source of TNF-a is from macrophages activated by 
agents such as bacterial lipopolysaccharide while TNF-P is produced mainly by 
activated T lymphocytes (Kuby, 1994). 
In general, production of the TNFs forms part of the inflammatory response to 
invasion by micro-organisms and is an important part, of host defenses against 
infection. In addition, TNFs can enhance the activity of granulocytes and eosinophils, 
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leading to increased phagocytosis and other mechanisms of cell killing. These effects 
undoubtedly contribute to the anti-tumor actions of the TNFs in vivo. However, TNFs 
also have a direct cytostatic or cytotoxic effect on some tumor cells, demonstrable in 
vitro (Clemens, 1991). -
Table 1.7 Properties of tumor necrosis factors (TNFs) 
(Clemens, 1991; Hamblin, 1993; Kuby, 1994) 
Cytokines Principal sources Principal effects 
TNF-a Macrophages, natural 
killer cells cytotoxic to tumor cells, 
Inflammatory responses, activation of 
“ “ granulocytes, eosinophils, macrophages 
TNF-P T cells 
b, Cytokine networks 
An important aspect of cytokine activity is that they interact with each other in a 
variety of networks in vivo. The following properties of cytokines attribute to the 
formation of networks: 
1. Many individual cytokines are produced by different cell types 
2. Most cytokines have several functions, i.e., pleiotropic 
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3. Cytokine actions are often shared by several different cytokines, i.e., redundant 
4. Cytokines often influence the synthesis of other cytokines, leading to a cascade of 
biological effects 
5. Cytokines often influence the action of other cytokines, either antagonistically or 
synergistically 
Cytokines, like other polypeptide hormones, initiate their action by binding to 
specific receptors on the surface of target cells. Sharing similar or overlapping 
biological effects by several cytokines is probably due to use of common receptors on 
the target cells or to similarities in the intracellular pathways activated by different 
receptors. The spectrum of effects brought about by a given cytokine can depend both 
on the nature and on the functional state of the target cell. The latter can of course be 
modulated by other influences (including other cytokines) which may regulate receptor 
activity andAn* post-receptor pathways inside the cell (Clemens, 1991). 
c. Role ofcytokines in the whole organism 
As cytokines are signaling molecules that mediate cell-to-cell interactions, it 
may be reasonable to think that cytokines have important roles in growth, development, 
and maintenance of advanced multicellular, multi-organ species (e.g. mammals) where 
the ordered and unharmed assembling and functioning of cells are vital to normal 
morphogenesis, not only during embryonic and neonatal development but also through 
adolescence and adulthood (Meager, 1990). 
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All exogenous stimuli cause localized perturbations in cells, resulting in 
imbalances in cellular metabolism. In most circumstances, cells will respond rapidly to 
counteract any subsequent imbalances by internal adjustment of metabolic processes 
and by the secretion of mediators to communicate the nature of the imbalance to other 
cells and stimulate such cells to respond accordingly. Therefore, the balanced 
production and actions of cytokines are essential in maintaining an organism in good 
condition. 
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1.1.4 Cytokine and receptor gene expression in mouse embryonic 
development 
During embryogenesis, the ordered proliferation of cells and their 
differentiation to form specialized organs and tissues is essential. This process of 
development must be largely dependent upon and controlled, both temporally and 
spatially, by the episodic and often cyclical release of many different cytokines and 
their subsequent concerted actions (Jessell and Melton, 1992). The roles that cytokines 
and their receptors play in murine development is at present largely circumstantial and 
unexplored. Nonetheless, knowledge about the changes in gene expression is essential 
to understanding mammalian development. 
Embryonic development can be roughly splitted into two phases which are 
separated at the time of implantation. Most of the analysis of differentially expressed 
genes were done with early mouse embryo during preimplantation. 
a. Murine embryonic stem cell model 
The preimplantation mouse embryo develops from a fertilized egg into a 
hatched blastocyst of about 100 cells over a 5-day period. The major problem in 
determining cytokine expression pattem during this period is the difficulty of obtaining 
sufficient quantities of timed embryos for experimentation. As an alternative approach, 
many studies have been performed on embryonal carcinoma (EC) cells or embryonic 
stem (ES) cells in an attempt to determine which factors might be expressed by cells of 
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the early embryo and what their function might be in regulating differentiation. EC 
cells from different teratocarcinomas have a variety of properties in common with the 
inner cell mass (ICM) ofthe blastocysts (Mummery and Eijnden-van-Raaij, 1990). ES 
cells, on the other hand, are pluripotential cells directly isolated from ICM of cultured 
mouse blastocysts (Evans and Kaufman, 1981). They have attracted much interest, 
both as a means of studying the molecular basis of early mouse development and as a 
route to genetically manipulating the genome of mice (Bradley et al., 1992; Koller and 
Smithies, 1992). 
b. Leukemia Inhibitory Factor (LIF) in mouse embryos 
Characterization ofthe expression and function of LIF in cultured ES cells has 
implicated this factor as a regulator of differentiation of the pluripotential stem cell in 
the early mouse embryo (Williams et al., 1988; Smith et al., 1988). LIF transcripts are 
found in preimplantation blastocysts (3.5 d.p.c.), extraembryonic tissue of7.5 d.p.c. and 
in the placenta of9.5, 10.5 and 12.5 d.p.c. embryos (Conquet and Brulet, 1990). Smith 
et al. (1992) detected the transcripts are significantly down-regulated by the onset of 
gastrulation at 7.5 days postcoitum. The studies by Stewart et al. (1992) revealed that 
LIF is essential for the implantation ofembryo. Female mice lacking a functional LIF 
gene by targeted mutagenesis are fertile, but their blastocysts fail to implant and do not 
develop. LIF regulates implantation by priming the uterus as well as regulating cell 
proliferation in the blastocyst. There is a coincidence in timing existed between arrival 
of the embryo in the uterine lumen and the onset of LIF expression, as delineated in 
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Figure 1.1. On the 5th day following implantation and decidua formation, the 
endometrial glands (site of LIF expression) degenerate and stop expressing LIF (Bhatt 
etal., 1991; Stewart, 1994). 
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Figure 1.1 Diagram summarizing the pattem ofLIF expression in the uterus during 
the first 5 days of pregnancy. The stages of embryonic development are 
shown with LIF expression from endometrial glands occurring on the 
4th-5th days. By the 5th day, implantation has occurred (Stewart, 1994). 
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c. IL_6 in mouse embryo 
IL-6 shares a number of biological properties with LIF. Murray et al. (1990) 
detected the presence ofboth IL-6 and LIF mRNAs in mouse blastocyst at 3.5 days of 
gestation. It is therefore believed that IL-6 also takes part in fetal development, perhaps 
in regulating differentiation and proliferation of uncommitted cells of the inner cell 
mass or in the development of the first hematopoietic stem cells (Lee, 1992). 
d. Ciliary Neurotrophic Factor (CNTF) in mouse embryo 
CNTF is a polypeptide that promotes the survival and/or differentiation of a 
variety of neuronal cell types including ciliary, sensory and sympathetic and motor 
neurons in vitro (Sendtner et al., 1994). Stewart and co-workers (1994) have been 
unable to detect CNTF transcripts in the mouse uterus or pre-implantation embryo. 
Homozygous mice deficient in CNTF production were derived and were overtly normal 
during the first postnatal weeks. But with increasing age, spinal motor neurons 
exhibited progressive degeneration which was functionally reflected by a significant 
reduction in muscle strength (Masu et al., 1993). This result has shown that 
elimination of CNTF gene did not affect the number of motor neurons during 
embryonic development but it has an essential maintenance function for motor neurons 
in the postnatal period. It seems the role of CNTF in embryogenesis remains elusive, 
however, CNTF is also able to maintain the pluripotentiality of ES cells (Conover et 
al., 1993). 
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e. TNF-a and TNF-P in mouse embryos 
These cytokines act as mediators of inflammatory response, programmed cell 
death and immune cell growth and differentiation. Kohchi and co-workers (1994) 
demonstrated that both TNF-a and TNF-P were expressed constitutively in almost 
all organs of fetus as well as the placenta from 10th day of gestation onwards. It was 
then hypothesized that the major roles of TNFs in embryonic development are their 
involvement in programmed cell death, in the regulation of cellular growth and 
differentiation, and in the remodeling of extracellular matrix (Wride and Sanders, 
1995). 
/ TGF-a in mouse embryos 
Matemal transcript of TGF-a apparently disappeared and were resynthesized in 
zygote to blastocyst stage (Rappolee et al., 1988). TGF-a is able to bind efficiently to 
the epidermal growth factor (EGF) receptor. Since both their mRNA and proteins are 
detectable in mid-gestation mouse embryos, TGF-a is proposed to be the primary 
component ofembryonic EGF activity (Popliker et al., 1987; Twardzik, 1985). 
g, TGF-P in mouse embryos 
TGF-P is a group of multi-functional regulatory polypeptides that are secreted 
by a variety of cells and play a crucial role in cell proliferation, differentiation, 
migration and extracellular matrix production (Roberts andSpom, 1990). Rappolee et 
al. (1988) detected that the transcription of TGF-pi started from fertilization and 
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increased continuously up to the blastocyst stage. TGF-pi protein has also been 
detected from day 9 onwards in post-implantation embryos (Heine et al., 1987). More 
recently, Kohchi et aL (1994) detected constitutive expression of TGF-p in various 
fetus organs and placenta from 10th day on throughout development, like TNF-a and 
TNF-P. Based on its activities and expression during mouse embryogenesis, TGF-P is 
widely assumed to have important functions in mammalian development. 
h, Stem cell factor/c-kit 
The recently described stem cell factor (SCF) (Zsebo et al., 1990) is the ligand 
binding to c-kit (Chabot et aL, 1988), a cell surface tyrosine kinase receptor. Evidence 
has been obtained that this SCF ligand/c-kit receptor pair is essential for hematopoiesis 
(Migliaccio et al., 1991; Ogawa et al., 1991). 
Following the discovery of the hematopoietic growth factor SCF, Matsui et aL 
(1990) studied the embryonic expression and reported that the transcript of SCF was 
found in mouse embryo aged from 10.5 to 17.5 d.p.c.. In situ hybridization study 
clearly revealed that the SCF gene was expressed in tissues associated with the 
migration, proliferation and differentiation of hematopoietic stem cells, presumptive 
melanoblasts and primordial germ cells, but were also present in a variety of other sites 
(Matsui et aL, 1990). 
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Palacios and Nishikawa (1992) have studied the developmentally regulated 
expression and function of c-kit receptor in mouse embryo using immunofluorescence 
staining method. The findings indicate that within the hematopoietic system of the 
developing embryo, cells bearing c-kit receptors are already present in the yolk sac at 
day 8 to 8.5 (before fetal blood circulation has started), c-kif hematopoietic cells are 
then found in the liver from day 10 and in the thymus from day 11 of gestation. In 
these organs, c-kit cells expand up to day 15 to 16 and thereafter switch off expression 
oic-kit. By day 17，only few hematopoietic cells are still c-kif in these organs. In the 
same study, the participation of SCF/c-kit system during lymphocyte development in 
mouse embryo was also demonstrated. SCF/c-kit contribute to this process by 
supporting cell survival and enhancing the response of the developing lymphoid 
precursor to other cytokines (e.g. IL-2, IL-3, IL-4, IL-7). 
I. Other cytokines in mouse embryos 
Hematopoietic development 
Many cytokines have been shown to be important to hematopoietic 
development, such as erythropoietin (Epo), G-CSF, M-CSF, GM-CSF, IL-1, IL-3, IL-4 
and IL-6 (Jessell and Melton, 1992). SCF and its receptor, c-kit, are also critical to 
hematopoiesis. Using murine embryonic stem (ES) cell in vitro system, Schmitt and 
co-workers (1991) demonstrated that Epo, M-CSF, IL-4, IL-6, SCF and c-kit were 
expressed during the first 24 days of ES cell differentiation. The expression of these 
cytokines reflects their importance in hematopoietic development. SCF and its receptor 
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{c-kit) have been reported to have IL-3 like activities on hematopoietic colony forming 
units (Anderson et al., 1990) while IL-4 in combination with IL-6 stimulates colony 
formation of various hematopoietic progenitor cells (Rennick et al., 1989). Thus it is 
conceivable that the expressed cytokines have important synergistic effects on very 
primitive hematopoietic cells as well as having crucial roles early in fetal development. 
In contrast, neither IL-3 nor GM-CSF transcripts were detected in the same experiment 
by Schmitt et al. (1991). These two factors are well documented to have effects on 
immature myeloid cells, however, the lack of transcription during the in vitro 
hematopoietic development of ES cells suggests that they are not critical to this 
process. 
The c-fms gene encodes the receptor for the M-CSF (Sherr et al., 1985). The 
interaction ofM-CSF with its receptor, c-fms, is required for the differentiation of cells 
in monocyte-macrophage lineage in the hematopoietic system. Regenstreif and Rossant 
(1989) utilized in situ hybridization techniques to determine the expression of c-fms and 
M-CSF during mouse embryogenesis. High levels of c-fms and M-CSF were detected 
in matemal tissue starting from 7.5 days of gestation. Their transcripts were observed 
in embryonic tissues only from 9.5 days onwards. The time course and spatial pattem 
of expression of these two genes suggest a functional role for the c-fms receptor and its 
ligand, M-CSF, in embryonic development. 
The insulin-like growth factors (IGFs) are considered primarily as fetal mitogen 
involved in the development of embryonal tissues (Haselbacher et al., 1985). IGF-I 
mRNA transcripts are detected at every stage from the fully grown, meiotically 
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competent oocyte to the blastocyst stages of development. The expression pattem 
changed dramatically in which the level declined from the oocyte to 8-cell embryo and 
then increased from the 8-cell to blastocyst stages (Doherty et al., 1994). 
J. Cytokine receptors 
Cytokine molecules mediate their biological function by binding to specific 
receptors expressed on target cells. The evidence that cytokines are present in embryos 
has now become unquestionable. The effects of such molecules could be regulated by 
their abundance and tissue specificity during development or by alterations in the 
expression of either the receptors to which they bind or other elements in the signaling 
pathway that they induce (Mummery and van den Eijnden-van Raaij, 1990). From the 
in vitro studies, there are clear indication that the expression of cytokine receptors is 
indeed modulated during differentiation and for at least some of these there is 
differential expression in embryos themselves. For example, Schmitt and co-workers 
(1991), using murine ES cell system, detected the expression of IL-lR type I，IL-3R, 
IL-4R, IL-6R, EpoR, G-CSFR and c-fms in differentiated ES cells and their levels 
increased throughout the time course of the experiment. IL-3 expression was not 
observed at any time during ES cell development, though its receptor was detected as 
early as day 4 of ES cell differentiation. In most cases, the receptor genes were 
transcribed before the corresponding cytokines genes (Schmitt et al., 1991). In another 
study by Mummery and Eijnden-van Raaij (1990), receptors for TGF-P was found in 
both undifferentiated and differentiated ES cells. Other studies were also carried out 
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for other cytokine receptors, like IGF-II receptors were detected on blastocysts and both 
IGF-I and IGF-II receptors in membrane preparations of day 9-12 gestation mouse 
embryos (Smith et aL, 1987). EGF receptors were found present on embryonic and 
extraembryonic tissues. The earliest time of detection was on giant trophoblast cells of 
a 5-day blastocyst grown for 2-3 days in culture (Adamson and Meek, 1984). 
There is an emerging body of literature in which cytokines or their genes were 
detected during murine embryogenesis. The observations of the studies were 
summarized in Table 1.8. 
Chapter 1 Introduction and Background ]_}_ 
Table 1.8 Summary of cytokine gene expression in mouse embryos. 
Factors Occurrence Reference 
IL-la • Absent in mid-late embryos (10-17 d.p.c.) Kohchi et al., 1994 
IL-ip • Blastocyst stage Rothstein et aL, 1992 
• Absent in mid-late embryos (10-17 d.p.c.) Kohchi et al., 1994 
IL-3 • Absent in 3.5 d.p.c. blastocyst Murray et al., 1990 
• Absent in mid-late embryos (10-17 d.p.c.) Kohchi et al., 1994 
IL-6 • 8-cell stage and blastocyst Rothstein et al., 1992 
• 3.5 d.p.c. Blastocysts Murray et al., 1990 
• Absent in mid-late embryos (10-17 d.p.c.) Kohchi et aL, 1994 
LIF • 3.5 d.p.c. Blastocysts Conquet and Brulet, 1990 
Murray etal, 1990 
• Uterus during the first 5 days of pregnancy Bhatt et aL, 1988 
• Extraembryonic ectoderm of7.5 d.p.c. embryos Conquet and Brulet, 1990 
and 9.5，10.5，12.5 d.p.c. placentas 
• Absent in mid-late embryos (10-17 d.p.c.) Kohchi et aL, 1994 
GM-CSF • Absent in 3.5 d.p.c. blastocysts Murray et al., 1990 
G-CSF • Absent in 3.5 d.p.c blastocyst Rappolee et al., 1988 
• Absent in mid-late embryos (10-17 d.p.c.) Kohchi et al., 1994 
M-CSF & • In matemal tissue from 7.5 d.p.c. onwards Regenstreif and Rossant, 
c-fms In embryonic tissue starting from 9.5 d.p.c. 1989 
IGF-I • Oocyte to blastocyst Doherty etaL, 1994 
EGF • Absent in 3.5 d.p.c blastocyst Rappolee et al, 1988 
NGF-P • Absent in 3.5 d.p.c blastocyst Rappolee et al., 1988 
bFGF • Absent in 3.5 d.p.c blastocyst Rappolee et al., 1988 
PDGF-A • 3.5 d.p.c. blastocyst Rappolee et al., 1988 
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Table 1.8 (continued) 
Factors Occurrence Reference 
TGF-a • 3.5 d.p.c. blastocyst Rappolee et al., 1988 
• 7 d.p.c. embryos and onwards Popliker et al., 1987 
TGF-p • 3.5 d.p.c. blastocyst Rappolee et al., 1988 
• 9 d.p.c. embryos and onwards Heine et al., 1987 
• Placentas (10-17 d.p.c.) Kohchi et al.’ 1994 
All embryo organs (10 d.p.c. and onwards) 
TNF-a • Placentas (10-17 d.p.c.) Kohchi et al., 1994 
All embryo organs (10 d.p.c. and onwards) 
TNF-P • Placentas (10-17 d.p.c.) Kohchi et aL, 1994 
All embryo organs (10 d.p.c. and onwards) 
SCF • 10.5-17.5 d.p.c. Matsui et al., 1990 
c-kit • Increases from 8 d.p.c. to 15 d.p.c. and Palacois and Nishikawa, 
decreases thereafter 1992 
IFN-y • Blastocyst stage Rothstein etal., 1992 
• Absent in mid-late embryos (10-17 d.p.c.) Kohchi et al., 1994 
CNTF • Absent in uterus or preimplantation embryo Stewart, 1994 
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1.2 Neuropoietic cytokines 
A number of cytokines sharing limited sequence homology have been grouped 
as a family because of partially overlapping biological activities, receptor subunit 
promiscuity, and the prediction of a shared secondary structure. Since several of these 
cytokines regulate gene expression and cell number in the nervous and hematopoietic 
systems, this specific group is termed the neuropoietic cytokine family (Fann and 
Patterson, 1994). This unusual family of cytokine could mediate ‘cross-talk，between 
the nervous and immune systems, in both directions. 
1.2.1 Family members 
Inaugural members of the neuropoietic family include leukemia inhibitory 
factor (LIF), interleukin-6 (IL-6), oncostatin M (OSM), ciliary neurotrophic factor 
(CNTF) andinterleukin-ll (IL-11) (Patterson, 1994; Tadamitsu, 1994). 
Although they share only very limited sequence homology, they exert very 
similar effects on a variety oftissues. Several of these proteins can, for instance, induce 
the same set of acute-phase response proteins in liver, support the self renewal of 
cultured embryonic stem cells, inhibit lipogenesis, and enhance the survival of cultured 
motor neurons. Despite their limited homology, the neuropoietic cytokines are 
predicted to share a four antiparallel helix bundle secondary structure. These ligands of 
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very similar structure bind to receptor subunits that share various degrees ofhomology. 
Subsequent studies on the receptors have revealed not only structural homology among 
receptors but the sharing of a common receptor transducing subunit (gpl30) and similar 
signal-transduction pathways (Fann and Patterson, 1994). 
1.2.2 Shared signal transducer gpl30 
The overlaps in receptors and signal cascades offer a convenient molecular 
explanation for the often redundant biological activities of the neuropoietic cytokines. 
IL-6, LIF, OSM, CNTF and IL-11 receptor systems are known to utilize a common 
signal transducer, gpl30. Signals from these cytokines are believed to be initiated by 
the ligand-induced homo- or heterodimerization of gpl30, which leads to the 
interaction of their cytoplasmic regions, resulting in activation of associated tyrosine 
kinase(s). The receptor binding complexes for the family members are schematically 
illustrated in Figure 1.2. 
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Figure 1.2 Common signal-transducing receptor components belonging to the 
neuropoietic cytokine family (adapted from Tadamitsu et aL, 1994). 
Chapter 1 Introduction and Background ]_}_ 
1.2.3 LIF, CNTF and OSM inhibit differentiation of embryonic stem cells 
In the case of UF receptor (LIFR) system, the LIFR forms a one-to-one 
heterodimer with gpl30 (Figure 1.2), and this combination generates a high affinity 
LIF-binding site. Interestingly, OSM also binds with LIFR-gpl30 complex with high 
affinity in addition to its own receptor complex which consists of OSMR and gpl30 
(Gearing et al., 1992). The high affinity form ofCNTF receptor includes LIFR-gpl30 
plus a separate CNTFR subunit. The sharing of receptor by LIF, OSM and CNTF 
serves to explain the similar biological functions mediated by these cytokines. Among 
the multiple functions, maintenance of the undifferentiated state of embryonic stem 
cells play an important role in embryonic development. 
LIF has long been documented for its ability to inhibit the differentiation of 
pluripotent embryonic stem cells in vitro (Williams et al., 1988; Smith et al., 1988). 
Later, CNTF (Conover et al., 1993) and OSM (Rose et al., 1994) were also 
demonstrated that they are similar to LIF in its ability to maintain the pluripotent 
phenotype of these cells. Since these cytokines have certain in vitro effect on 
embryonic development, gene targeting experiment by ‘knock-out，mice were carried 
out to study their in vivo functions (Masu et al., 1993; Stewart et al., 1992). To 
achieve this, gene clones of the cytokines have to be ready first. The human and mouse 
clones for LIF (Gearing et al., 1987; Gough et al., 1988) and CNTF (Kaupmann et al., 
1991; Lam et al., 1991) genes were subsequently obtained and sequenced. However, 
only human OSM gene was cloned and sequenced by Malik et al. in 1989. Although 
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murine OSM has been identified, it has not yet been cloned and analyzed up to the 
commencement of this project. Therefore, a preliminary study of murine OSM gene 
would be included in the present project. 
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1.3 Biology of Oncostatin M (OSM) 
OSM was originally isolated from media conditioned by U937 human 
histiocytic leukemia cells induced to differentiate into macrophage-like cells by 
treatment with phorbol 12-myristate 13-acetate (PMA) (Zarling et al., 1986). It was 
later determined as a growth regulatory molecule which could inhibit the growth of 
certain tumor cell lines and thus it won the name 'onco-' ‘statin，(i.e. tumor stable). 
1.3.1 Physical properties of OSM 
OSM is found as a glycoprotein, with a Mr of 28,000 (Zarling et al., 1986). 
This mature form of 196 amino acids is derived from a 252 amino acid precursor by 
the removal of a 25 amino acid N-terminal leader sequence and a 31 amino acid C-
terminal peptide. There are two potential N-glycosylation sites together with sites for 
0-linked glycosylation (Bruce et aL, 1992). It is a very stable protein, retaining its 
biological activity in extremes of pH (2-11) and after heating (56。C，1 hr). 
The mature OSM is predicted to adopt a four alpha-helical bundle structure 
similar to that determined for growth hormone (Rose et al., 1991). OSM contains five 
cysteine residues with four of them forming two intramolecular disulfide bonds. The 
second of these has been found to be essential of biological activity. Mutational 
analysis has shown that the amphiphilic C-terminal helix, and other discontinuous 
regions within the molecule, are involved in receptor binding (Kallestad et al., 1991). 
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1.3.2 Biological activities ofOSM 
OSM acts to inhibit or promote various biological activities according to the cell 
type affected and they are summarized in Table 1.9. As with most cytokines, these 
activities are diverse and, in some cases, appear contradictory. 
Table 1.9 Summary of in vitro effects ofOSM (Bruce et al., 1992). 
Solid tumor cells 
• Inhibits the growth of a solid tumor cells from a wide variety of sources. 
Hematopoietic cells 
• Induces the differentiation ofhuman and murine leukemia cells. 
Embryonic stem cells 
• Blocks the differentiation of totipotent mouse embryonic stem cells. 
AIDS-related Kaposi's sarcoma cells 
• Is produced by AIDS-KS cells and acts in autocrine and paracrine fashion as a 
mitogen for these cells. 
• Stimulates the production ofIL-6 in these cells. 
Hepatic cells 
• Induces acute phase protein synthesis in HepG2 cells. 
Fibroblasts 
• Stimulates the growth of several fibroblast cell lines. 
Endothelial cells 
• Induces the production ofIL-6 in human umbilical vein endothelial cells. 
• Inhibits the growth of bovine aortic endothelial cells and stimulates the cells to 
produce plasminogen activator. 
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The range of in vitro biological activities presently attributed to OSM suggests 
its potential role in hematopoiesis, embryonic development, inflammation and 
pathogenesis of AIDS-related Kaposi's sarcoma. 
1.3.3 Molecular aspect of OSM 
Zarling's group first discovered OSM in 1986 and the human OSM was later 
cloned and sequenced by Malik et aL in 1989. The entire human gene spans 
approximately 5 kb, and the mRNA (about 2 kb) is composed of 3 exons. The first 
exon contains 5，non-coding region and the coding sequence of the first 10 amino acids 
of the signal peptide. The second exon encodes the remainder of the signal peptide and 
the first 34 residues of the mature molecule. The last exon encodes the remaining 193 
amino acids and contains all ofthe 3，non-coding sequences present in the cDNA clone 
(Malik et aL, 1989). The human OSM cDNA and protein precursor were schematically 
represented in Figure 1.3. The 3，non-coding region contains several AU rich sections 
of the type that have been suggested to confer mRNA instability (Shaw and Kamen, 
1986). 
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Figure 1.3 Schematic representation of the human OSM cDNA and protein 
precursors. 
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The gene for human OSM is located at 22ql2 and lies within about 10 kb of the 
LIF gene (Rose et al., 1993). The expression of OSM mRNA is generally restricted to 
hematopoietic cells including activated T cells and monocytes. The only known non-
hematopoietic source of OSM RNA is cells derived from AIDS-related Kaposi's 
sarcoma (Miles et al., 1992). 
Although murine OSM has already been identified, its gene has not yet been 
cloned up to the day this project started. Therefore, a preliminary study on mouse OSM 
gene was carried out in the present study. 
、 I 
I 
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1.4 Aims of the study 
Cytokines mediate cell-to-cell communication and bring about subsequent 
reactions. During development, cytokines may act as direct intercellular signals by 
regulating proliferation andA)r differentiation of competent target cells or as indirect 
signals by inducing the expression of a cascade of other genes which in their tum affect 
specific developmental events. However, the function of cytokines in embryogenesis 
remains an intriguing problem. 
To understand better the role of cytokines and their receptors during the 
embryonic development, we investigated the expression of a number of genes. 
Expression studies were accomplished by using reverse transcription-polymerase chain 
reaction (RT-PCR) to determine the relative mRNA levels throughout the 
developmental time course (7.5 d.p.c. to 17.5 d.p.c.). The time point at which a 
particular factor and its receptor undergoes significant expression will suggest when 
that factor begins to play a role in the differentiation process. Likewise, the lack of 
expression of a particular cytokine and its receptor would be strong evidence that the 
factor is not critical for development at that stage. 
In the second part of the study, our focus tumed to a novel cytokine, Oncostatin 
M (OSM), which belongs to the growing neuropoietic family. OSM, like LIF and 
CNTF, is demonstrated to inhibit differentiation of pluripotential embryonic stem cells. 
This property implicates its role in development. Human OSM gene has already been 
cloned and sequenced for a long time but, interestingly, the mouse gene was not studied 
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Up to date. In the present project, a preliminary molecular analysis on mouse OSM 
gene was carried out. The PCR-cloned human OSM gene fragments were used as 
probe to hybridize with mouse genome. 
Hopefully, the expression pattem of various cytokines during mouse embryonic 
development will accelerate the understanding of mammalian embryogenesis and 
speeding the benefits of embryo biotechnology to human health. 
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The aim of this part of project was to determine the expression profile of 
various cytokines during mouse embryonic development using Reverse Transcription-
Polymerase Chain Reaction (RT-PCR). This method allows the detection and semi-
quantitative assessment of changes in mRNA level of various genes at different stages 
of development. 
Total RNA of five different time-pointed mouse embryos, ranging from 7.5 
d.p.c. to 17.5 d.p.c.，were extracted for analysis. Entire population of mRNA molecules 
was first converted into cDNA by priming with Oligo d(T) in reverse transcription. For 
significant comparisons of the small amounts of cytokine mRNAs present in embryos, 
cDNA samples were first normalized by PCR using primers specific for the 
constitutively expressed glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene. 
The normalization allowed the use ofequivalent amounts of cDNA for each assay. 
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The analysis procedures following normalization are schematically depicted in 
Figure 2.1. To detect expression levels in 5 different time points of embryo, specific 
primers designed for over 30 mouse cytokine and receptor genes were initially used to 
perform 50 cycle-PCR upon normalized RT samples. Intensity of the resulted DNA 
bands as visualized in agarose gel provided a means of comparison of mRNA quantity 
among the 5 developmental stages. According to the results, cytokines and receptors 
were then grouped into 'no expression', ‘consistent, and ‘regulatory' types 
correspondingly. To achieve semi-quantitative assessment, cycle number of PCR 
should lie on the exponential phase of amplification. Therefore, cycle number for 
‘consistenf group were further lowered down to 30. 
Southern hybridization was used to prove that ‘no expression' cytokines was 
due to the absence of their mRNA from mouse embryos at selected stages but not due 
to any problem occurred in PCR. On the other hand, cycle titration of PCR, dot 
blotting and subsequent hybridization were done for all genes having consistent or 
regulatory levels as observed at 30- or 50-cycle PCR. These steps could achieve the 
following goals: 
1) validation of amplified sequences by hybridizing with internal probes 
2) more precise quantitative comparison of gene expression level by densitometric 
measurement of the hybridization signals 
The appropriate amplification cycle schedule for each gene was determined 
empirically to allow a minimal yet detectable signal, lying on the exponential phase of 
PCR. 
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Total RNAs from 7.5，9.5，11.5, 15.5 and 17.5 d.p.c. embryos 
Normalization ofRT samples with GAPDH gene 
• 
PCR for 50 cycles with specific primers 
^ ~^~~~~~~~~~~~::^^—^  
^^^^^^j9re^^j^^^ ^^^^^^^^^^^^^^^^^^^^^^^^^ (^^^^^^^^^lat^^^^^^ 
• • 
Southem hybridization Cycle titration 
(+ve control included) and 
Dot blotting 
• 




Cycle titration & 
Dot blotting 
Figure 2.1 Schematic representation of the analysis procedures. 
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2.1.2 Design of primers 
The design of primers for different gene sequences was facilitated by an 
automated primer search software OLIGO 3.4 and governed by the following criteria: 
1) No inter- or intra-strand complementary base pairing, especially at 3’ ends of the 
primers 
2) No secondary priming site with sufficient homology, so that only one PCR 
product can be generated 
3) Region of target sequence with internal secondary structure should be avoided 
4) Length ranges from 20 - 25 nucleotides such that they have similar melting 
temperature 
5) Primer specifying an amplified segment of 300 to 700 bp in size 
6) Priming sites not further than 2 - 3 kb from the 3，end of the mRNA 
7) Primer flanking target sequence containing an intron-exon border so that PCR 
product derived from genomic DNA will be greater in length 
Fidelity of those amplified sequences of each cytokine or receptor gene by 
specific upper and lower primers was checked by hybridization to an oligonucleotide 
probe priming to the internal sequence flanked by the pair of primers. Sequence of the 
internal probes were designed in a similar fashion with PCR primers. 
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2.2 Materials 
2.2.1 Chemicals and Reagents 
1 Kb DNA marker, 1.0 [xg/[il GIBCO/BRL O^o. 15615-016) 
2-Mercaptoethanol Sigma Q^o. 7154) 
Agarose, type I: low EEO Sigma fNo. A-6013) 
Blocking reagent Boehringer Marmheim fNo. 1096 176) 
Bromophenol blue Bio-Rad Q^o. 161 -0404) 
Cesium chloride (CsCl) Sigma ONfo. C-4036) 
Diethyl pyrocarbonate (DEPC) Sigma QS[o. D-5758) 
Dithiothretol (DDT) GIBCO/BRL Q^o. 28025-013) 
dNTPs Pharmacia Inc. (No. 27-2035) 
Absolute ethanol, analytical grade Ajax chemicals (No. 214) 
Ethidium bromide Sigma QSfo. E-8751) 
Ethylene diamine tetraacetic acid (EDTA) Sigma (No. E-5134) 
Ficoll Sigma (No. F-4375) 
Guanidinium thiocyanate Fluka Biochemika fNo. 50990) 
Hydrochloric acid (HC1), 36% Ajax chemicals C^o. 1367) 
Lithium chloride (LiCl) Sigma O^o. L-8895) 
Magnesium chloride (MgCy，25mM Advanced Biotechnologies fNo. AB-0288) 
Maleic acid Fluka Biochemika fNo. 63180) 
N-lauroylsarcosine, sodium salt Sigma O^o. L-5125) 
Nylon membrane, positively charged Boehringer Mannheim (No. 1029 299) 
Oligo d(T)i2-i8 Pharmacia Inc. (No. 7858) 
Potassium chloride (KC1) Sigma (No. 4504) | 
Potassium phosphate (KH2PO4) Sigma Q<^ o. 5379) 
Sodium acetate Q^aOAc) Sigma 0s[o. S-8750) 
Sodium chloride (NaCl) Sigma GSTo. S-9625) 
Sodium citrate, trisodium salt: dihydrate Sigma fNo. S-4641) 
Sodium hydroxide C^aOH) Sigma OSFo. S-5881) 
Sodium dodecyl sulfate (SDS) Sigma Q^o. L-5750) 
Sodium phosphate (NhHPOJ Sigma O^o. S-0876) 
Synergel Diversified Biotech Inc. (No. Syn 100) 
Tris base Sigma (No. T-8524) 
Tween 20, EIA purity Bio-Rad (No. 170-6531) 
Xylene cyanol FF Bio-Rad (No. 161 -0423) 
Remark: The water used throughout the experiments was of ultrapure grade. 
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2.2.2 Enzymes 
Moloney murine leukemia virus reverse transcriptase (200U/^il) was obtained from 
GIBCO/BRL GSk). 28025-013) 
Recombinant RNasin ribonuclease inhibitor (40U/p,l) was obtained from Promega (No. 
N2511) 
ThermoprimePi^ DNA polymerase (5U/^il) was obtained from Advanced 
Biotechnologies CNo. AB-0301) 
2.2.3 Buffers 
5x First strand buffer 
It was obtained from GIBCO/BRL which contained 250mM Tris-HCl (pU 8.3), 375 , 
I 
mM KC1 and 15mM MgCl】. 丨 
• 
Buffer 1 (Maleic acid buffer) 
Buffer 1 contained O.lM maleic acid, 0.15M NaCl. The pH was adjusted to 7.5 with 
solid NaOH. 
Buffer 2 (Blocking solution) 
This buffer was prepared by diluting the blocking reagent stock (see page 47) 1:10 in 
buffer 1. 
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Buffer 3 (Detection buffer) 
The buffer was composed ofO.lM Tris-HCl (pU 9.5), O.lM NaCl and 50mM MgCl2. 
Washing buffer 
The buffer was made from maleic acid buffer (buffer 1) added with 0.3% (v/v) Tween 
20. 
Gel-loading buffer (1 Ox) 
The buffer contained 0.42% bromophenol blue, 0.42% xylene cyanole FF and 25% 
Ficoll in sterilized water. It was stored at room temperature. 
TEoj buffer 




TAE buffer (Tris-acetate-EDTA buffer), Amresco 
I 
25x stock solution was diluted before use. lx buffer contained 0.04M Tris base, 0.04M , 
acetate and 0.001M EDTA. 
Thermoprime^ius DNA polymerase reaction buffer IV(lOx), Advanced Biotechnologies 
The buffer contained 200mM ¢^4)2864, 750mM Tris-HCl (pH 9.0) and 0.1% (w/v) 
Tween 
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2.2.4 Solutions 
Blocking reagent stock solution (lOx conc.) 
10 g ofblocking reagent was dissolved in 100 ml buffer 1. The solution was heated to 
facilitate dissolution before autoclaving. The stock solution was stored at -20°C for 
long-term storage. 
Ethidium bromide solution 
lg of ethidium bromide was added to 100 ml of H2O. The bottle was wrapped with 
aluminium foil and stored at room temperature. 
Guanidinium thiocyanate solution 
4M guanidinium thiocyanate and O.lM Tris-HCl pH 7.5 in DEPC-treated water. The 1 
solution was stored at room temperature. 0.143 ml 2-mercaptoethanol (14M stock 
« 
solution, Sigma) was added to 20 ml of the guanidinium thiocyanate solution 
i 
immediately before use. | 
» 
Hybridization solution 
Hybridization solution was composed of 5x SSC, 1% (w/v) blocking reagent, 0.1% N-
lauroylsarcosine and 0.02% SDS. It was stored at 4。C. 
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PBS (Phosphate-buffered saline) 
8g ofNaCl，0.2g ofKCl，1.44g of Na2HPO4 and 0.24g of KH2PO4 were dissolved in 
800 ml of distilled H2O and the pH was adjusted to 7.4 with HC1. Water was added to 
make 1 litre buffer which was then sterilized by autoclaving. 
SDS (10%) 
100g of SDS was dissolved in 1000 ml ofH2O which was heated to assist dissolution. 
The pH was adjusted to 7.2 with a few drops of concentrated HC1. 
SSC (20x) 
0.3M NaCl and 0.03M sodium citrate. 175.3g ofNaCl and 88.2g of sodium citrate 
were dissolved in 800 ml ofH2O. The pH was then adjusted to 7.0 with a few drops of 
a 10N solution of NaOH. Water was added to make 1 liter solution which was 
sterilized by autoclaving. 
Tris-HCl, lM(pH7.5) 
121g of Tris base was dissolved in 800 ml H2O and pH was adjusted to 7.5 with 
concentrated HC1. Water was added to make 1 liter. 
2.2.5 Probe labeling and detection kits 
DIG Oligonucleotide 3'-end labeling kit Boehringer Mannheim fNo. 1362372) 
DIG luminescent detection kit Boehringer Mannheim fNo• 1363514) 
Chapter 2 Cytokine gene expression during mouse embryonic development 101 
2.2.6 Primers and internal probes 
Table 2.1 Sequence ofprimer pairs and internal probes specific for mouse cytokines. 
Cytokine Sequence (5，to 3，） size (bp) 
GAPDH upperprimer ACCACAGTCCATGCCATCAC 452 
lower primer TCCACCACCCTGTTGCTGTA 
IL- la upper primer ACAGTATCAGCAACGTCAAGCAA 
lower primer CCGACTTTGTTCTTTGGTGGCA 546 
internal probe GGCAACTCCTTCAGCAACACG 
EL-1P upper primer GAGCTTCAGGCAGGCAGTATC 
lower primer GTATAGATTCTTTCCTTTGAGGC 3 82 
internal probe CACTTGTTGGTTGATATTCTGTC 
IL-lR tI upper primer ATGGAAGGGATGACTATGTTGGA 
lower primer GCTGCAGCCTCTTATGATGGG 506 
internal probe TGATCTCCGTTGGGCTGGCA 
IL-lR tII upper primer AAGGAACAACCACGGAACCCAT 
lowerprimer AGCCCTGCGTTTACACCGTCT 446 
intemal probe CGCAATGCTCCAGGAGAACGT 
IL-2 upper primer AGCAGCTGTTGATGGACCTAC 
lower primer GCAGGAGGTACATAGTTATTGAG 380 
internal probe TCCTCAGAAAGTCCACCACAGT 
EL-2Ra upper primer ATTCCGGGATACAAGGCTCTAC 
lowerprimer TGTTGCCAGGTGAGCCCGCT 332 
internal probe GAAGTGTGGGAAAACGGGGTG 
IL-3 upper primer ATAGGGAAGCTCCCAGAACCTGAACTC 
lower primer AGACCCCTGGCAGCGCAGAGTCATTC 207 
internal probe ATTCGCAGATGTAGGCAGGCA 
EL-3R upper primer TACACACGATTTTCTAATGGAGATA 
(AIC2A) lower primer TAGATGCTGTTGGGTAGGAATAG 326 
intemal probe GAGCTGAAGGAGGAACCTGAC 
nL-3R upper primer ATACACGATTTTCCATCACAAACG 
(AIC2B) lower primer TAGATGCTGTTGGGTAGGAATAG 325 
internal probe GAGCTGAAGGAGGAACCTGAC 
IL-4 upper primer TGACGCACAGAGCTATTGATGG 
lower primer ATGATGCTCTTTAGGCTTTCCAG 422 
internal probe AGCTGGGGGTTGAGACC 
！ 
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Table 2.1 Sequence of primer pairs and internal probes specific for mouse cytokines. 
(Cont'd) 
Cytokine Sequence (5，to 3，） size (bp) 
IL-5 upper primer TTGACAAGCAATGAGACGATGAG 
lowerprimer CAGTTTGAGGCCAGCCTGCG 507 
intemal probe TCCCTACTCATAAAAATCACCAG 
IL-6 upper primer TGAGAAAA GAGTTGTGCAATGGC 
lower primer GAATGTCCACAAACTGATATGCTT 479 
internal probe GTTAGGAGAGCATTGGAAATTGG 
IL-10 upper primer TAGAGCTGCGGACTGCCTTCA 
lower primer TCATGGCCTTGTAGACACCTTG 351 
internal probe GGAGAAATCGATGACAGCGCC 
IL-11 upper primer CTAGCTGCACAATGAGAGAC 
lower primer CCAGTCCAAGGTCAGGTGCA 396 
intemal probe GATGCTTCCCCAGGCTGAGG 
LIF upper primer TCTCTTCATTTCCTATTACACAGC 
lowerprimer GACCACCACACTTATGACTTGC 415 
intemal probe CACGGTACTTGTTGCACAGAC ‘ 
LIFR-1 upper primer TCATCACCACCTTCGAAAATAGC 
lower primer CCGCATATTTTAAGTGACCGCT 415 
internal probe TGGTGCAACTCATCTCGGTCT 
LIFR-s upper primer TCATCACCACCTTCGAAAATAGC 
lower primer GCGCAACAATGGGAGCCAGT 340 
intemal probe TGGTGCAACTCATCTCGGTCT ‘ 
gpl30 upper primer ATATTGCCCAGTGGTCACCTCA 
lower primer CACCGTCTACACTATCCACCAG 429 
intemal probe CGGACCTTGAGAACACTTGCA 
SCF-1 upperprimer TGGACAAGTTCTCAAATATTTCT 313 
lower primer GCAACAGGGGGTAACATAAAT 
SCF-s upperprimer TGGACAAGTTCTCAAATATTTCT 281 
lower primer CTTTGCGGCTTTCCCTTTCT 
* internal probe CGAAGAGGCCAGAAACTAGATC 
c-kit upper primer GCGGATCACAAAGATTTGCGATT 
lower primer CGAGTTGACCCTCACGGAATG 472 
internal probe CCCAGGGATGCCGGTCGAC 
*internalprobe specific to both forms of SCF. 
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Table 2.1 Sequence of primer pairs and internal probes specific for mouse cytokines. 
(Cont'd) 
Cytokine Sequence (5' to 3，） size (bp) 
M-CSF upper primer GTAGCCACATGATTGGGAATGG 
lower primer TCATGGAAAGTTCGGACACAGG 304 
internalprobe GTTCTGCTCCTCATAGTCCTTG 
c-fms upper primer TGCTCCACTTCTCCAGCCAAGTGGCTC 
lower primer AGGTGTTCACTGGAGCTCTCCTCTTCTG 607 
internalprobe TGGAGGAGGAAGCAGATCTGT 
GM-CSF upper primer TGGTCTACAGCCTCTCAGCAC 
lower primer AAGGGGATATCAGTCAGAAAGGT 364 
internal probe TAAGGCTGTCTATGAAATCCGCA 
G-CSF upper primer ATCCAGGCCAGCGGCTCGG 
lower primer GGGCTTTCTGCTCAGGTCTAG 467 
internal probe AGAAGTGAAGGCTGGCATGGC 
CNTF upper primer CTGGCTAGCAAGGAAGATTCGT 
lower primer ATGAGAAGAAATGACACGGAGGT 484 
intemal probe TCTCCAATTGTGACAGGCATCC 
I 
IFN-Y upper primer AGGAACTGGCAAAAGGATGGTG 
lower primer GTGCTGGCAGAATTATTCTTATTG 353 
internal probe TCCTGCAGAGCCAGATTATCTC 
TGF-P upper primer CATGGAGCTGGTGAAACGGAAGCGCAT 丨 
lower primer CTCCAGTGACGTCAAAAGACAGCCACT 497 , 
intemal probe GTCCAAACTAAGGCTCGCCAG 
TNF-a upper primer TCCCCAAAGGGATGAGAAGTTC 
lower primer TCATACCAGGGTTTGAGCTCAG 411 
internal probe CACACTCAGATCATCTTCTC 
TNF-P upper primer AGCCCATCCACTCCCTCAGAA 
lower primer ATGCCGTCGGTGTGGGTGGA 423 
internal probe TTGTTGCTCAAAGAGAAGCCATG 
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2.3 Methods 
2.3.1 Preparation of total RNA from mouse embryos at different stages 
a. Mice dissection for embryo 
Pregnant ICR mice were obtained from the Animal House of the Chinese 
University ofHong Kong. Embryos were isolated from pregnant mice of 7.5, 9.5, 11.5， ; 
'1 
ij 
15.5 and 17.5-day postcoitum (d.p.c.). Deciduum (from 7.5 d.p.c. embryos) and | 
•| 
placenta (from 9.5, 11.5, 15.5 and 17.5 d.p.c. embryos) were isolated separately. ；丨 
I 
b. Guanidinium thiocyanate cell lysate 丨 
Each tissue was first washed in cold PBS and was passed through a 0.1 cm 
sterile stainless steel mesh. The cell suspension was then centrifuged and the resulted I 
cell pellet was resuspended in 0.5 ml PBS. The suspension was immediately added 
•‘ 
dropwise to appropriate volume of guanidinium thiocyanate (GT) solution with 
continuous vortexing. Vigorous mixing for rapid and complete homogenization was 
necessary for efficient protein denaturation with consequent elimination of nucleolytic 
damage to the RNA molecules. (Herrmann and Frischauf, 1987). The amount of GT 
solution was based on an estimation of 1.0 x 10^  cells in 40 ml GT solution. The cell 
lysate was stored at -70°C until it was further processed. 
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c. Isolation of RNA by centrifugation through CsCl gradient 
RNA was isolated using a modified guanidinium thiocyanate/cesium chloride 
method in which RNA was separated from the GT homogenate by ultracentrifugation 
through a dense cushion of CsCl (Chirgwin et al, 1979). The frozen cell lysate was 
first thawed by incubating in a 65°C waterbath with vigorous shaking. After complete 
thaw, it was further heated at 65°C for 5 min and then quickly chilled on ice. By 
passing through a 25-gauze needle for several times, large DNA molecules were ， 
]i 
sheared. This step prevented the formation of impenetrable DNA mat which would i 
,' 
I 
otherwise block the sedimentation of RNA molecules and thereby facilitating the '1: 
' i 
1 
purification ofRNA (Herrmann and Frischauf, 1987). 2 ml of each sample was then ‘ 
layered on top of a 1 ml cushion of 5.7M CsCl in a DEPC-treated thin-walled 
polyallomer tube (Beckman, No. 328874) and centrifuged in a SW 60 Ti rotor at 32,000 | 
rpm for 18 hours at 18°C. 丨 
After centrifugation, supernatant was removed by aspiration while the cushion 「 
I 令 
was discarded by inverting the tube very quickly. The RNA pellet which should be 
translucent and located at the bottom of the tube was allowed to dry thoroughly in the 
inverted tube. The bottom 0.5 cm of the ultracentrifuge tube was then cut off with a 
new sterile scalpel blade and the RNA pellet was subsequently rinsed out and 
resuspended in total 400 ^1 DEPC-treated water and transferred to a new microfuge 
tube. Complete dissolution of RNA was achieved by vigorous vortexing for a few 
minutes. The RNA suspension was transferred to another new microfuge tube after 
brief spinning. RNA was then precipitated with 0.3M NaOAc and 2.5 volumes of 
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absolute ethanol. The tube was centrifuged at 13,000 g for 30 min at room temperature. 
The RNA pellet was washed with 70% and absolute ethanol sequentially and dried 
under vacuum. 
d. Spectrophotometric determination of RNA amount 
The amount of RNA was estimated by spectrophotometric measurement at 
OD26o- Absorbance of RNA was measured by GeneQuant, RNAyDNA calculator ‘ 
'i i|i 
(Pharmacia, No. 80-2103-93). One OD unit corresponds to approximately 40 p,g/ml for ;| 
j 
single-stranded RNA and so concentration ofRNA equals to 40 ^g/ml x dilution factor ] 
X OD26o- The ratio between the readings at 260nm and 280nm provides an estimate of I 
the purity of the RNA. Pure preparations of RNA should have OD260 丨 OD280 values of 1 
I 
2.0 (Maniatis et al., 1982). 1 
2.3.2 Preparation of embryo sections 
i 
Several freshly isolated embryos from each stage were fixed in cold Bouin's 
fluid for 24 hours. The cold Bouin's fluid would avoid the rapid autolysis of the organ. 
Dehydration was carried out in an ascending concentration series of ethanol (70%, 
80%, 95% and 2 changes for 100%). The embryos were further cleared in xylene and 
later embedded in Paraplast paraffin wax (m.p. 56-58°C). The embedded specimens 
were sectioned with microtome (Leica 2035 Biocut) into sections of 5 ^m thickness 
which were fixed on glass slide with albumin. The sections were stained with Mayer's 
hematoxylin and eosin (H & E staining). 
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2.3.3 Primers and internal probes 
Oligonucleotide primers and internal probes were custom synthesized by 
Integrated DNA Technologies, Inc. The oligonucleotides were purified by gel filtration 
column and obtained as lyophilized powder. 
Upon arrival, powder of primer was first dissolved in 500 i^l TE。！ buffer and the 
concentration was determined by OD measurement at 260 nm according to the 、 
|j 







Concentration ofoligonucleotide (pmol/ ^il) = OD260 / e x dilution factor x 1000 
where s corresponds to the summation of extinction coefficient of the bases in an 
oligomer. 
(A=11.5, T = 8.8, G=11.7, C = 7.3) 
A working solution of 25 pmol/ i^l of each primer was prepared. ' 
v' 
• i 
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2.3.4 Cytokine mRNA Phenotyping by Reverse transcription-Polymerase 
chain reaction 
a. Reverse transcription (First strand cDNA synthesis) 
RNA was denatured at 65°C for 5 min and then chilled on ice. It was 
subsequently reverse transcribed into cDNA in a 20-p,l standard reaction mixture 
\ 
containing lp,g of total cellular RNA, lx Gibco/BRL First strand buffer (50mM Tris- ！丨 
! 
HC1, pH 8.3，75mM KC1 and 3mM MgCy, 40 U ofRNasin (Promega)，0.1 i^g Oligo :| 
J： 
ir 
d(T)i2.i8, lOmM DTT, 0.2mM of each dNTP and 200 U of Moloney murine leukemia '( 
!丨 
virus reverse transcriptase (Gibco/BRL). The reaction mixture was incubated at 37°C | 
( 
for 60 min and the reaction was terminated by immediate chilling on ice and was stored , 
I 
at -20。C until next procedure. I 
b, Polymerase chain reaction (PCR) 
- , ' 
cDNAs of interest were amplified by PCR using specific primers. The reverse-
transcribed (RT) products were first denatured by boiling for 10 min and then quickly 
chilled on ice just before PCR. The amplification was done in a total volume of 50 p,l 
with denatured RT sample equivalent to 0.1 ^g of total RNA, lx PCR buffer [20mM 
pSffl[4)2SO4, 75mM Tris-HCl, pH 9.0 and 0.01% (w/v) Tween], 25 mM MgCl^, lOmM 
1 
of each dNTP, 1 ^iM of each upper and lower primers and 0.25 U of ThermoprimeP'^  
DNA polymerase (Advanced Biotechnologies). The mixture was overlaid with mineral 
oil (Sigma) and then amplified with the PTC-100 Programmable Thermal controller 
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(MJ Research, Inc.), using profile of denaturation at 94°C for 1 min, primer annealing at 
5-10°C below its melting temperature for 1 min and extension at 72°C for 1 min. The 
samples were stored at -20°C before analysis. 
2.3.5 Analysis ofPCR products with agarose gel electrophoresis 
PCR products were separated and analyzed in agarose gel by electrophoresis. 
^ 
DNA molecules ranged from 100 to less than 1000 bp were electrophoresed in a gel ii 
！ 
mixture of 0.7% (w/v) agarose and 1.5% Synergel (a novel gelling and sieving agent f 
I 
1' 
for improving agarose gel performance). The Synergel-agarose binary gel was the i 
functional equivalent of3.5% (w/v) agarose. ‘ 
Buffer used for gel preparation and electrophoresis was lx TAE buffer 、 
containing 0.5 ^ig/ml ethidium bromide. Usually, 10 or 15 i^l of each sample was 
subjected to electrophoresis at 5-10 V/cm of gel. Migration of the tracking dyes was an 
indicator of the separation process which was stopped when the first dye front : 
(bromophenol blue) reached two-third of the gel length. EtBr-stained DNA molecules 
were visualized with a UY transilluminator. The EtBr-nucleic acid complexes emit 
orange red fluorescent light upon UV irradiation. The gel was then photographed with 
Polaroid (MP-4) land camera with Polaroid 667 films (ASA 3000). 
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2.3.6 Analysis of PCR products with Southern blotting 
Cytokine gene products after 50-cycle PCR which could not be visualized in 
agarose gel were considered absent in the initial template. In other words, those 
cytokines did not express in corresponding embryo tissues. The result was verified by 
Southern blotting using oligonucleotide probes corresponding to the intemal sequences 









Samples, together with a positive control, were electrophoresed in 2% agarose ！ 
gel and stained with EtBr as described in previous section {Section 2.3.5). The gel was 
then photographed with a fluorescent scale under UV light. Unused areas of the gel 
were cut off with a clean scalpel blade on a piece of Saran wrap. The DNA in the gel 
was subsequently depurinated in 2 gel volumes of 0.2M HC1 for 10 min at room 
temperature with gentle shaking and rinsed briefly with double distilled water. The 
¥ 
DNA was then ready for transfer to a positively charged nylon membrane by capillary 
blotting at alkaline pH. 
The blotting apparatus was assembled as shown in Figure 2.2. The transfer 
solution was 0.4M NaOH. Any air bubbles between gel and membrane or 3MM paper 
above were removed by rolling a clean pipette over the surfaces. The edge of gel was 
surrounded with Saran wrap to prevent ‘short circuits', in which transfer solution flows 
directly from the reservoir to the dry paper towels above the membrane, rather than 
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passing through the gel. The transfer was done for 4 hours and the set-up was 
disassembled. Remains of the gel was restained with EtBr (1 |ig/ml) to see if any DNA 
remained in it. The membrane was rinsed in 2x SSC solution and then air-dried at 
room temperature. The dried membrane was finally placed between two 3MM paper 
sandwiched within two glass plates and baked at 120。C for 30 min to fix the DNA on it. 
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Figure 2.2 Assembly of Southern blotting. 
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b. Probe labeling 
Oligonucleotides probes were labeled at their 3，end with terminal transferase 
by the incorporation of a single digoxygenin-labelled dideoxyuridine-triphosphate 
(DIG-ddUTP). The labeling reaction was performed according to the instruction 
manual (Boehringer Mannheim). In brief, 4 |il of 5x reaction buffer, 4 ^1 of 25mM 
C0Cl2 solution, 100 pmol oligonucleotides, 1 p,l of lmM DIG-ddUTP solution, 1 \x\ of 
^ 
50 U/ \x\ terminal transferase were mixed in a microcentrifuge placed on ice. Sterile ; 
I 
water was added to make final volume of 20 ^il. The mixture was then incubated at 
i:, 
!： 
37°C for 15 min and chilled on ice afterwards. 1 [i\ of 20 mg/ml glycogen solution was j' 
mixed with 200 ^1 0.2mM EDTA solution (pH 8.0) and then 2 ^il ofthe dilution was 
added to the tube to stop the reaction. The labeled oligonucleotide was precipitated ‘ 
with 2.5 ^il 4M LiCl and 75 i^l prechilled (-20°C) ethanol for 30 min at -70°C，recovered 
by centrifugation at 13,000g for 15 min. The pellet was washed with 50 ^1 cold 70% 
ethanol, vacuum dried and finally resuspended in 50 ^il sterile water. The labeled probe 
i 
was stored at -20°C before use. ‘ 
c. Prehybridization 
The baked membrane was placed into a roller bottle, which was later filled with 
at least 20 ml hybridization solution per 100 cm^ of membrane for 2 hours at the 
hybridization temperature with constant rotation in a hybridization incubator (Robbins 
Scientific Co., Model 1000). 
! 
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The hybridization temperature depended on the length and sequence of the 
oligonucleotide probes. Hybridization was carried out at 5-10°C below the melting 
temperature (TJ ofthe probe. Assuming 2。C for A-T bond and 4。C for G-C bond, T^ 
of a synthetic oligonucleotides was estimated by summing up the total number. 
[i.e. T„ = (A-T)x2。C + (G-C)x4。C ] 
d. Hybridization 
After the prehybridization process, the solution was replaced by about 2.5 ml 
per 100 cm2 membrane of hybridization solution. 3’ end-DIG labeled oligonucleotide 
probe was subsequently added to the hybridization fluid to a final concentration of 10 
pmoVml. Hybridization was carried out at a particular hybridization temperature for 16 
hours with constant rotation. The membrane was then washed twice with 0.5 x SSC/ 
0.1% (w/v) SDS for 15 min. The washed membrane was directly used for detection of 
hybridized oligonucleotides. 
e, Detection of DIG-labeled probe 
The hybridized probe was detected using DIG luminescent detection kit from 
Boehringer Mannheim. The procedures followed the instructions of the kit. Briefly, 
the DIG-labeled probe were first immunodetected with anti-DIG, Fab fragments 
conjugated to alkaline phosphatase and were then visualized with the 
chemiluminescence substrate CSPD. Enzymatic dephosphorylation of CSPD by 
alkaline phosphatase led to a light emission at a maximum wavelength of 477 nm 
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which was recorded on X ray films. The intensity of the hybridization signals was 
evaluated by the imaging densitometer (Bio-Rad Model GS-670). 
2.3.7 Cycle titration of PCR and dot blotting of regulatory cytokine mRNA 
a. Cycle titration ofPCR 
Cytokines which showed regulation at different stages of embryonic \ 
\ \ 
development as observed in agarose gel electrophoresis after 30-cycle PCR were | 
！ 
Studied with semi-quantitative PCR. It was achieved by titrating PCR against different | 
cycles of amplification which were within the exponential phase ofPCR. The reactions 
were prepared as a master mixture to enhance accuracy. The conditions of reaction 
were the same as described in Section 2.3.4 b and subjected to 5，10，15, 20，25 and 30 
cycles of amplification. The PCR products were kept at -20。C prior to analysis by dot 
blotting. 
• V. 
b. Dot blotting 
The PCR products were verified and quantified by dot blotting on a nylon 
( ,f 
membrane and subsequent hybridization with specific intemal probes. 5 - 15 ^ 1 ofPCR | 
I 
products (varied with different sets of sample) was added to 200 i^l of denaturing 
i 
solution (0.2M NaOH) in an eppendorf tube and incubated for 15 minutes at room 
temperature. During the incubation period, the nylon membrane was fixed and pre-
setted with sterile water in a Bio-dot SF Microfiltration apparatus (Bio-Rad, No. 170-
Chapter 2 Cytokine gene expression during mouse embryonic development 101 
6542) applied with gentle vacuum. Denatured samples were then loaded into wells and 
blotted on membrane with gentle suction force. Each sample was chased by adding 400 
^il 20x SSC to each well and sucking it through. The nylon membrane was then 
dissembled from the apparatus and allowed to dry in air. DNA was fixed to membrane 
by baking at 120。C for 30 min. 
The hybridization and detection procedures following dot blotting were the , 
same as used with Southern blots {Section 2.3.6 b-e), The hybridization signal in dots | 
were scanned and photographed by imaging densitometer (Bio-Rad Model GS-670) j 
j 
and video copy processor (Mitsubishi P68E) respectively. 
蓍 
I' 
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2.4 Results 
2.4.1 Sagittal sections of mouse embryos 
The gestation period for the ICR mouse embryo is generally 19-20 days. 
Referring to Figure 2.3, embryo is in its early organogenesis on day 7.5 and 9.5 while 
it enters organogenesis on day 11.5. From 14 days onwards, a complete body plan of 
, 
the embryo establishes and the fetus develops and grows in size (Hogan et al., 1994). i 




The rate at which embryo develops is hardly identical. Developmental 
differences between embryos of the same nominal age inevitably exist. The rate varies 
to certain degree from hatch to hatch or even from individual to individual within the 
same mother. Due to the minor differences, embryos from at least 3 mothers were 
pooled together and total RNAs were extracted from the pooled tissue. This practice 丨! 
minimized the individual difference. 
Typical embryos from each selected stage (7.5, 9.5, 11.5, 15.5 and 17.5 d.p.c.) 
were preserved and sectioned laterally. The embryo sections were stained with 
Mayer's hematoxylin and eosin and were presented in Figure 2.4. 
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Figure 2.3 Time course of mouse embryonic development (adapted from Hogan 
etal., 1994). 
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Figure 2.4 Sagittal sections of mouse embryo stained with hematoxylin and eosin. 
a： 7.5 d.p.c. embryo in deciduum; b: 9.5 d.p.c. and c: 11.5 d.p.c. embryos. 
(*：• 
I-
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Figure 2.4 Sagittal sections of mouse embryo stained with hematoxylin and eosin. 
(cont'd) 
d: 15.5d.p.c. and e: 17.5d.p.c. embryos. 
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On 7.5 d.p.c., amnion had been formed and allantois was appearing. The whole 
embryo was very small in size (2mm in length) and was encased in deciduum (Figure 
2.4a). For embryo at this early stage, deciduum was taken as the mother tissue control. 
By 9.5days (Figure 2.4b), tuming of embryo had taken place and heart began to beat 
(Hogan et al., 1994). The length varied from 1.2 to 2.5mm. From this day onwards, 
condensation of the forelimb and hindlimb bud began. The extremities and tail were 
enlarging rapidly. By 11.5 d.p.c.(Figure 2.4c)，a footplate had formed in the anterior 
limb bud. The posterior limb buds were not yet divided into leg and foot. These 
projecting appendages curved forward or inward (Theiler, 1972). Most embryos were 
6-7mm long at this stage. The liver was growing rapidly. As seen from Figure 2.4d, 
the liver was well developed in 15.5 d.p.c. embryo and contained scattered blood-
forming foci (Theiler, 1972). The length of embryos varied from 11.5 to 14mm. 
Separation of toes and fingers was prominent. They were clearly divergent and became 
parallel on day 17.5 (Figure 2.4e). The skin was wrinkled and thickened, and the 
subcutaneous veins were no longer distinctly visible. The length of this late stage 
embryo ranged from 16.5 to 20mm depending on the degrees of curvature of the 
fetuses. 
2.4.2 Preparation of total RNA 
RNA ofmouse embryos and their placentas aged at 7.5，9.5, 11.5, 15.5 and 17.5 
d.p.c. were prepared by ultracentrifugation through CsCl gradient. The quantity of 
RNA was estimated by spectrophotometric measurement at OD260 and the results were 
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tabulated in Table 2.2. As embryo is in close connection with mother body, its 
cytokine expression level is easily contaminated with mother's contribution. Due to 
this reason, placenta at each time point was then taken as mother tissue control and its 
cytokine expression profile was also determined for comparison. 
Table 2.2 Extraction of RNA from mouse embryo and placenta aged at 7.5, 9.5, 
11.5，15.5 and 17.5 d.p.c.. Two batches of each sample were prepared 
and labeled as B1 and B2. 
A) Embryo RNA 
7.5 9.5 11.5 15.5 17.5 
B1 B2 B1 B2 B1 B2 B1 B2 B1 B2 
OD260 0.024 0.409 0.948 1.357 0.333 1.848 0.226 1.901 0.195 0.481 
OD280 0.013 0.268 0.532 0.781 0.157 1.051 0.107 1.088 0.086 0.282 
OD260/OD280 1-846 1.527 1.782 1.736 2.121 1.753 2.112 1.748 2.270 1.705 
c0nc. (Klg/ i^l) 0.19 1.64 3.79 5.43 2.66 7.37 1.81 7.60 1.56 1.92 
B) Placenta RNA 
7.5 9.5 11.5 15.5 17.5 
B1 B2 B1 B2 B1 B2 B1 B2 B1 B2 
OD 0.687 0.502 0.369 0.264 0.138 0.422 0.648 0.708 0.482 0.400 U"260 
OD280 0.366 0.291 0.203 0.150 0.080 0.240 0.368 0.436 0.270 0.224 
OD260/OD280 1-877 1.728 1.818 1.761 1.725 1.758 1.761 1.624 1.785 1.786 
c0nc. (^g/^il) 2.75 2.01 1.48 1.06 0.55 1.69 2.59 2.83 1.93 1.60 
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2.4.3 Cytokine mRNA phenotyping 
The expression profile of various cytokines was determined for 7.5, 9.5, 11.5， 
15.5 and 17.5 d.p.c. mouse embryo and their respective placenta. For significant 
comparisons of cytokine mRNAs present in embryos, cDNA samples were first 
normalized by a constitutively expressed glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) gene. This normalization step allowed the use of equivalent amounts of 
cDNA for each assay. As shown in Figure 2.5, band intensities of PCR product 
丨  
(GAPDH) of all time-point samples were roughly the same. Cytokine mRNA 
phenotyping was carried out only after RT samples were equalized. i 
i 
According to the analysis procedures depicted in Figure 2.1, phenotyping 
started with 50-cycle-PCR using 30 pairs of specially designed primers for different 
cytokine or receptor genes. Intensity of the resulted DNA bands as visualized in 
agarose gel provided a means of comparison of mRNA quantity among the 5 
developmental stages. To achieve semi-quantitative assessment, cycle number of PCR j 
should lie on the exponential phase of amplification. Therefore, cycle number for those 
cytokines which gave consistent band intensity was further lowered down to thirty. 
The results for the 30 cytokine and cytokine receptor genes were summarized in Figure 
2.6. 
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Figure 2.5 Normalization of RT samples by GAPDH gene. RNA of 7.5，9.5, 11.5， 
15.5 and 17.5d.p.c. embryos were analyzed by RT-PCR. The PCR was 
performed with primers specific for GAPDH gene for 25 cycles and the 
products were sequentially resolved in Synergel-agarose gel and stained with 
EtBr. A fragment of GAPDH gene which was 452 bp in size was generated. 
Lane M is the 1 kb DNA ladder of which 2 marker bands were labeled with 
their standard sizes on the left-hand-side. 
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Figure 2.6 Diagram summarizing the result of mRNA phenotyping for 30 cyotkines 
and cytokine receptors. 
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The qualitative test discriminated 3 types of cytokines in terms of their 
expression, they were 'no expression’，‘consistent，and 'regulatory' types. 
a. Southern hybridization for 'no expression，cytokines 
‘No expression' cytokines included IL-la, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, 
IL-11, GM-CSF, G-CSF, IFN-y and TNF-p. Their transcripts were detected neither in 
embryo nor in placenta RNA throughout the 5 stages. 
i 
It is essential to include a positive control for the claim of absence of particular 
transcript. Positive control was cDNA sample previously demonstrated to contain the 
particular cytokine transcript being amplified with the same pair of primer with the test 
sample. The control was subjected to PCR in an experiment together with embryo or 
placenta RT products using the same master mix. It serves to eliminate the possibility 
I 
of primer problem or the PCR reaction itself. The PCR products were analyzed by ‘ 
Southem hybridization to an internal oligonucleotide. As seen from the X-ray films in 
Figure 2.7 - 2.9, signals were seen only at the positive control bands. 
Although IL-la, IL-2 and IL-3 gene transcripts were absent in mouse embryo or 
placenta, their receptor IL-lR tI, IL-lR tII, IL-2Ra, IL-3R(AIC2A) and IL-3R(AIC2B) 
were interestingly expressed. Despite GM-CSF, G-CSF and IL-3 are the major 
hematopoietic growth factors, they were not detected throughout the embryonic 
development. IL-6 and IL-11 also intervene hematopoiesis, however, they were also 
Chapter 2 Cytokine gene expression during mouse embryonic development 101 
absent in mouse embryo. These two cytokines both belong to the neuropoietic family 
which also include LIF, OSM and CNTF. The members share a receptor component 
gpl30 whose transcripts were found in both embryo and placenta tissues. 
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Figure 2.7 Southern hybridization of 'no expression' cytokines IL-la, IL-2, IL-3 and 
IL-4. PCR products from embryo tissue as well as positive control (+ve) were 
electrophoresed on EtBr-stained Synergel-agarose gel and transferred to nylon 
membrane subsequently. The membrane bound DNAs were then hybridized 
with corresponding intemal probe and signals were recorded on X-ray film (see 
Section 2.3.6 for details). Sizes of some marker bands and the corresponding 
PCR products were marked on the left- and right-hand-side respectively. 
M: 1 kb DNA ladder. 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc and e: 17.5 dpc) 
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Figure 2.8 Southern hybridization of 'no expression' cytokines IL-5, IL-6, IL-10 and 
IL-11. PCR products from embryo tissue as well as positive control (+ve) were 
electrophoresed on EtBr-stained Synergel-agarose gel and transferred to nylon 
membrane subsequently. The membrane bound DNAs were then hybridized 
with corresponding internal probe and signals were recorded on X-ray film (see 
Section 2.3.6 for details). Sizes of some marker bands and the corresponding 
PCR products were marked on the left- and right-hand-side respectively. 
M: 1 kb DNA ladder. 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5dpc;d: 15.5 dpcande: 17.5dpc) 
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GM-CSF G-CSF 
bp M a b c d e +ve M a b c d e +ve 
^^^^^^^^^^^^^^^^^^^^^^^^^ bp nnmimiigijmiminiiiPiiiiiiiiiiiiiiii 
3 4 4 ^ ^ ^ ^ ^ ^ ^ ^ H 364 bp - g : g | | ^ ^ ^ ^ m 467 bp 
“ “ 









bp M a b c d e +ve bp M a b c d e +ve 
3 4 4 l | ^ ^ | ^ | ^ m | 3 5 3 bp 3 4 4 l | Q | ^ j ^ ^ ^ Q 423 bp 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
^^^^^m ^ ^ ^ ^ ^ ™ ^^^^™ ^^^^M 
^^^^^m ^ ^ ^ ^ ^ M 
H^Mi^ ^^ ^^ ^^ ^^ *^®^^ fc^ i^ ^™= ^H^^^^^^^^^B^^^^^^^^^H^1 
Figure 2.9 Southern hybridization of 'no expression' cytokines GM-CSF, G-CSF, IFN-y, 
TNF-P. PCR products from embryo tissue as well as positive control (+ve) were 
electrophoresed on EtBr-stained Synergel-agarose gel and transferred to nylon 
membrane subsequently. The membrane bound DNAs were then hybridized 
with corresponding internal probe and signals were recorded on X-ray film (see 
Section 2.3.6 for details). Sizes of some marker bands and the corresponding 
PCR products were marked on the left- and right-hand-side respectively. 
M: lkbDNA ladder. 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc and e: 17.5 dpc) 
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b. ‘Consistent，and ‘regulatory，cytokines in embryo and placenta 
After 50 cycles of amplification, most cytokines exhibited identical band 
intensities among the five embryo samples. They were regarded as ‘consistent’ 
cytokines. However, they might not truly express at the same level throughout the 
selected developmental stages. Since the cycle number (50 cycles) was large, the 
reaction most probably had reached its saturation phase. At this stage, even different ； 
] 
levels of initial transcript in different samples would eventually result into same amount 丨 
of PCR products. Therefore, PCR lowered down to 30 cycles were necessarily 
performed for these ‘consistent’ cytokines in the next step. 
Once the cycle number was reduced to 30，most 'consistent' cytokine gene 
tumed into ‘regulatory，，i.e. band intensities varied among different embryonic stages 
under investigation. These included IL-lR tI and IL-lR tII, IL-3R(AIC2A) and IL-
3R(AIC2B), CNTF, c-fms, TNF-a and TGF-p. While SCF-1, SCF-s, c-kit, M-CSF, 
LIFR-1, LIFR-s and gpl30 still remained at constant levels (Figure 2.6). 
IL-ip, IL-2Ra and LIF were found to be ‘regulatory，at 50 cycles. These 
cytokines were said to be present in low abundance for the PCR still not reached the 
plateau phase even after 50 cycles of amplification. 
Here, semi-quantitative PCR was adopted to compare the relative amount of 
cytokine genes in 7.5，9.5, 11.5, 15.5 and 17.5 d.p.c. mouse embryos and placentas. 
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PCR products sampled at different cycles were analyzed by dot blotting and probing 
with an internal probe. As for comparative purpose, the data should be collected during 
the exponential phase ofPCR reaction. The appropriate cycle schedule for each of the 
cytokines was determined empirically. The band intensity appeared on agarose gel 
provided certain hints for finding out the suitable cycle numbers. 
Dot blotting provides a rapid and convenient method for the analysis of large 
number of samples. Use of intemal oligonucleotide as probe confers an additional level ： 
of specificity in the reaction as only the specific PCR product will bind with the probe 
under the correct stringency of hybridization and washing. The fluorescent signal was 
exposed on X-ray film for record. Intensity of the signal was proportional to the 
amount of the homologous sequences to which the probe bound on. Experiments for 
batch 1 and batch 2 mouse RNA samples were done independently. The results were 
found to be consistent for the 2 batches of sample and only one set of photos was 
included here. Figure 2.10 - 2.14 showed the results for embryo samples while those 
of placenta samples were shown in figure 2.15 - 2.19. 
The hybridized dots were scanned with imaging densitometer and their 
intensities were digitalized as adjusted volume (OD x nrni^ ). The dot intensity reflected 
the abundance of PCR product binding to the probe and was used for comparison. 
Table 2.3 listed the adjusted volume for cytokines at a particular PCR cycle number 
where a prominent trend was observed. With regards to dot intensity, the trend of 
cytokine expression was verbally described in Table 2.4. 
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IL-ip I L- lR t I 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5 5 
10 10 
1 5 1 5 
2 0 2 0 • * • _ _ 9.3 5.9 9.6 15.4 21.2 
2 5 • - 參 17.2 - 3.6 5.7 2 5 • # _ % # 35.6 27.9 43.6 49.3 50.2 
30 _ • • m _ 44.5 14.9 19.1 26.8 32.4 3 0 •春眷鲁春 59.7 60.4 74.4 78.5 77.6 
a b c d e a b c d e 
IL-lRtII IL-2Ra 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5| I - - • - 5| |-----
1 0 1 0 - - - 2.4 2.7 
15 15 . 1.8 - - 2.1 2.4 
2 0 • ^ • 19.9 3.5 4.5 5.9 9.3 2 0 翁 - 舊 5.1 - - 3.6 7.5 
2 5 _ 眷 • _ 眷 32.9 17.7 13.9 21.0 29.1 2 5 • ' # # 33.9 7.8 8.7 29.1 39.6 
30 書 • ‘ • • • 48.2 42.0 37.3 38.3 49.5 3O • • • # • 54.6 21.6 21.6 54.3 63.6 
a b c d e a b c d e 
Figure 2.10 Dot-blot hybridization of mouse embryo IL-ip, IL-lRtI, IL-lRtII and IL-2Ra 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume(OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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IL-3R(AIC2A) 
Cycles Adjusted volume ODxmm^ 
5| [ ~ ~ “ ” - ~ - -
10 
15 - - - - -
20 
2 5 缓 _ • - - 3.6 9.2 16.4 
3 0 _ m m _ _ 16.4 16.8 20.4 25.0 34.6 
a b c d e 
IL-3R(AIC2B) 





2 5 , - - 3.0 3.2 4.1 
3 0 鲁 • # . m _ 5.1 8.3 15.9 16.1 16.6 
a b c d e 
Figure 2.11 Dot-blot hybridization of mouse embryo IL-3R(AIC2A) and IL-3R(AIC2B) 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume (OD x mm )^ of the dots as determined by imaging densitometer 
were listed in the box on the right-hand-side, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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LIF LIFR-1 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5 | [ ~ ~ - - - - 5 | 
1 0 1 0 _ 參 眷 _ _ 15.5 9.3 16.5 22.8 22.0 
1 5 1 5 • # • 書 _ 19.5 15.3 19.0 24.5 26.3 
2 0 會 3.9 - - - 2 0 _ 書 • _ 秦 21.0 14.5 18.3 26.8 27.3 
2 5 • 書 參 23.1 - 5.7 12.3 2 5 _ _ # _ # 22.5 13.3 22.0 29.5 28.3 
3 0 • _ • _ _ 56.1 22.8 25.5 32.1 38.7 3 0 _ _ • 0 _ 24.8 16.8 20.8 31.3 33.0 
a b c d e a b c d e 
LIFR-s gpl30 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5| I • • • • 5| L - . . • 
10 10 
1 5 - » 缴 3 . 1 3 . 0 3 . 4 5 . 7 5 . 4 i r 赢 急 峰 愈 暴 
U l J • _ • _ • 13.5 14.4 14.1 16.3 14.7 
9 0 _ • 參 # # 27.8 21.6 27.8 29.4 27.8 。八 應 豳 急 • • 
^ ^ ZU 眷 _ _ • _ 20.3 19.0 18.4 19.1 18.0 
2 ^ W # # # # 38.5 32.2 33.5 34.8 32.8 ，< _ 雌 血 血 急 
Z j ^ — — 零 零 2j _ # _ # _ 19.9 22.2 20.1 22.0 19.5 
^ 0 m # # # # 41.6 33.3 35.4 36.4 36.1 m 类惠赢• • 
J U w 零 — 零 审 3 0 • 書 • • # 22.0 20.3 20.7 19.5 21.5 
a b c d e a b c d e 
Figure 2.12 Dot-blot hybridization of mouse embryo LIF, LIFR-1, LIFR-s and gpl30 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume (OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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SCF-1 SCF-s 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5 | [ ~ ~ - - - - 5 | \ - ~ ~ - - - -
10 10 
15 15 
2 0 》 書 • 4.8 3.5 4.5 13.6 13.2 2 0 華 • _ - - 5.6 7.6 9.8 
2 5 • # 眷 書 • 23.2 19.6 21.8 27.4 26.8 2 5 春 • 雄 ⑩ • 26.8 22.4 23.4 29.9 32.8 
30 • • • • _ 32.6 28.6 32.4 34.6 34.o| 30 • • • # • 47.3 44.5 52.3 55.4 55.4 
a b c d e a b c d e 
c-kit CNTF 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5 • - - - • 5 _ _ • _ • 
1 0 1 0 
15 15 
2 0 • 4 _ • 7 . 4 3 . 0 3 . 9 1 0 . 6 1 2 . 1 2 0 餐 會 缴 餘 « 4 . 5 4 . 8 4 . 2 4 . 2 3 . 0 
2 5 • • _ • 眷 24.0 19.5 23.3 26.6 27.4 2 5 • • _ # • 24.0 21.6 24.6 23.4 23.4 
3 0 • # 氟 _ _ 3 3 6 儿 3 33.4 34.3 35.4 3 0 _ # _ _ _ 49.2 43.2 45.6 43.8 43.2 
a b c d e a b c d e 
Figure 2.13 Dot-blot hybridization of mouse embryo SCF-1, SCF-s, c-kit and CNTF 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume (OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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M-CSF c-fms 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5| [ ~ - - - - 5 | 1^  - - - -
10 10 
15 15 
2 0 凝 # - - - 8.1 11.4 2 0 • • • 拳 6.6 - 8.1 15.1 19.4 
2 5 • _ • _ m 9.3 9.3 13.8 18.9 19.2 2 5 _ « _ # # 33.2 11.6 35.2 40.9 40.5 
3 0 _ • m • 推 28.2 25.8 31.5 35.7 34.8 3 0 : _ : # # # # 51.1 34.4 50.2 51.6 54.6 
a b c d e a b c d e 
TGF-p TNF-a 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
5 | |- - - • - 5 | L . _ • • 
10 10 
15 15 
2 0 祷 • _ _ - 2.7 15.3 17.4 18.6 2 0 - . . . 2.8 
9S m m 龜 _ • 25.2 25.2 32.4 32.4 33.9 0《 叙 • 晨 
Z) 攀 攀 W m 警 25 翁 « # _ 6.2 2.8 6.6 13.6 17.4 
a n m _ • 塵 _ 35.4 39.3 42.0 42.0 44.7 。八 皇急赢 * _ 
J ^ 9 W W 零 W 3 0 # • • • H ^ 25.0 15.5 23.8 27.6 32.2 
a b c d e a b c d e 
Figure 2.14 Dot-blot hybridization of mouse embryo M-CSF, c-fms, TGF-P and TNF-a 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume(OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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IL-lp(p) IL-lRtI (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume QDxmm^ 
2 4 2 4 參 • _ 4.7 - 2.0 13.4 14.4 
3 0 _ _ • 10.4 9.4 8.8 2.0 - 3 0 • ” * _ • 21.2 3.7 5.5 21.6 16.8 
33 _ • _ • _ 30.3 32.1 30.6 21.6 20.4 3 3 # • • # 攀 30.4 15.6 16.8 28.6 24.2 
3 6 • _ # # • 25.8 28.8 29.1 23.4 19.8 3 6 # # • # # 33.8 22.6 22.8 29.8 30.0 
4 0 _ _ # _ _ 31.2 32.1 32.7 28.2 27.6 4 0 攀 拳 _ • _ 39.6 36.2 32.8 33.8 35.2 
a b c d e a b c d e 
IL-lRtII Op) IL-2Ra (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
1 6 _ 參 • 書 赛 19.6 13.8 4.9 4.1 3.8 1 8 
1 8 _ _ _ _ • 19.8 22.4 15.2 14.4 14.8 2 0 
2 0 # # _ _ • 29.0 26.1 24.8 23.4 22.4 2 2 3.8 - -
2 2 0 H _ _ 眷 33.6 31.0 25.8 27.8 27.6 2 4 _ _ 奢 2.8 6.4 4.6 - -
2 4 4 | 參 參 H 眷 36.0 40.8 30.2 30.8 31.3 3 0 _ • 泰 書 • 17.8 19.0 17.2 7.4 4.2 
a b c d e a b c d e 
Figure 2.15 Dot-blot hybridization of mouse placental IL-ip, IL-lRtI, IL-lRtII and IL-2Ra 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume(OD x mm�）of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, (p) denotes placental tissue, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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IL-3R(AIC2A) (p) 




2 4 . 4.2 - - - -
3 0 # # 書 • ' # 46.5 39.1 33.3 27.0 24.3 
a b c d e 
IL-3R(AIC2B) (p) 
Cycles Adjusted volume ODxmm^ 
18 
20 
2 2 » 着 * 14.7 7.0 3.2 - -
2 4 眷 卷 _ _ • 22.3 22.8 18.5 15.5 9.0 
3 0 4 l 4 l i i 0 | P 61.0 62.5 62.5 52.1 60.8 
a b c d e 
Figure 2.16 Dot-blot hybridization of mouse placental IL-3R(AIC2A) and IL-3R(AIC2B) 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled internal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume(OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, (p) denotes placental tissue, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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LIF (p) LIFR-1 (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
18 25 
2 0 參 * - 3.4 3.3 2.8 - 3 0 • 眷 眷 • • 12.2 16.8 18.2 18.8 22.8 
2 2 • _ • , - 13.6 13.0 9.3 7.3 3 5 _ 眷 眷 _ # 12.6 18.2 20.0 24.6 26.6 
2 4 _ • _ • • 10.8 20.5 17.3 18.0 17.3 4 0 _ _ _ _ _ 14.2 19.2 22.4 30.2 27.8 
3 0 # _ 0 _ _ 48.5 45.8 44.0 48.8 44.5 4 5 • 書 _ # # " .0 21.0 24.8 33.2 31.2 
a b c d e a b c d e 
LIFR-s (p) gpl30(p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
2 0 - - - - - 2 0 
2 5 _ _ _ 9 f | 21.0 24.2 21.0 29.4 31.4 2 5 _ • 鲁 _ • 10.0 9.6 11.2 11.4 10.4 
3 0 # # _ _ H 24.8 27.4 27.6 29.2 32.6 3 0 # # _ 書 # 14.4 14.2 17.6 16.8 15.0 
3 5 書 _ _ _ _ 29.4 28.4 28.6 29.4 35.2 35 # • # # 眷 15.8 13.8 18.2 16.2 16.2 
4 0 # 0 _ _ _ 26.2 27.8 28.4 29.2 36.4 4 0 _ _ # • # 16.6 16.2 18.6 15.8 15.4 
a b c d e a b c d e 
Figure 2.17 Dot-blot hybridization of mouse placental LIF, LIFR-1, LIFR-s and gpl30 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled internal probe. The 
luminescent signals were recorded on X-rayfilm(seeiSec"V?«23.7fordetails). The 
adjusted volume(OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, (p) denotes placental tissue, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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SCF-1 (p) SCF-s (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
1 8 « 參 - . 3 . 4 6.6 7.4 1 8 參 _ - - 1.4 7.6 8.4 
2 0 參 # # • • 6.2 8.8 10.8 12.6 10.0 2 0 # • _ • 4.4 7.4 9.2 12.2 13.0 
22 _ • _ • _ 12.0 9.6 14.0 17.2 15.2 22 • _ _ _ • H-2 &8 13.6 20.6 18.8 
2 4 • • # # 眷 16.2 12.8 17.2 20.0 18.0 2 4 書 * • # _ 13.0 12.4 15.4 27.4 26.4 
3 0 H 9 H H H 32.2 30.4 32.0 31.6 30.4 3 0 # # 麵 | | | | 30.2 27.8 31.8 35.8 38.0 
a b c d e a b c d e 
C-kit (p) CNTF (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
18 _ ^ 11.6 3.8 3.4 3.2 3.0 18 * 3.5 - - - -
20 _ 擊 # • _ 22.6 21.6 16.4 20.2 21.2 20 ^ 3.9 3.3 - - -
2 2 # # H % _ 26.8 26.6 26.0 28.0 30.4 2 2 _ 务 ^ 12.8 8.4 7.2 
2 4 _ 眷 _ H H 28.0 28.2 27.4 27.6 32.0 2 4 # # • 18.6 17.0 12.2 7.2 6.4 
3 0 • • • • • 48.2 41.2 39.0 42.4 45.4 3 0 • • • • • 29.4 31.0 28.4 25.0 23.6 
a b c d e a b c d e 
Figure 2.18 Dot-blot hybridization of mouse placental SCF-1, SCF-s, c-kit and CNTF 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film (see Section 2.3.7 for details). The 
adjusted volume(OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, (p) denotes placental tissue, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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M-CSF (p) c-fms (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
18 * 春 % 场 - 3.5 3.8 3.9 3.5 1 6 - # • _ - 8.0 9.6 12.2 13.2 
2 0 缴 # • • 春 丄 6 15.2 13.0 17.2 15.4 1 8 發 * « • • 9.4 12.8 12.8 18.4 17.8 
2 2 0 # # # 着 20.8 27.0 27.0 27.2 30.0 2 0 • • • _ 書 17.6 18.6 18.0 24.0 23.8 
2 4 _ _ _ # # 28.8 34.4 34.6 37.0 36.6 2 2 • # # • 書 22.6 22.6 22.4 24.8 26.2 
3 0 • _ _ H • 43.2 40.4 41.8 43.0 43.2 2 4 # • • • _ 26.2 25.5 25.3 26.2 28.0 
a b c d e a b c d e 
TGF-p (p) TNF-a (p) 
Cycles Adjusted volume ODxmm^ Cycles Adjusted volume ODxmm^ 
1 8 - - - - - 1 8 
2 0 癱 • * « « 8.8 8.6 7.2 8.0 8.8 2 0 
2 2 • • • • • 16.1 15.7 13.5 12.6 12.0 2 2 
24 # • • • 拳 23.4 22.0 21.4 19.3 23.0 24 
30 # # # 41 % 33.0 32.0 32.4 34.0 37.6 30 3.7 2.8 2.6 2.2 2.3 
a b c d e a b c d e 
Figure 2.19 Dot-blot hybridization of mouse placental M-CSF, c-fins, TGF-p and TNF-a 
RT-PCR products. PCR products of different cycles of amplification (as marked) were 
dotted on nylon membrane and hybridized with DIG-labeled intemal probe. The 
luminescent signals were recorded on X-ray film(see5^ec"bw23.7fordetails). The 
adjusted volume(OD x mm )^ of the dots as determined by imaging densitometer were 
listed in the box on the right-hand-side, (p) denotes placental tissue, 
(a: 7.5 dpc; b: 9.5 dpc; c: 11.5 dpc; d: 15.5 dpc; e: 17.5 dpc) 
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Embryo Placenta 
No. Gene (d.p.c.) (d.p.c.) 
7.5 9.5 11.5 15.5 17.5 7.5 9.5 11.5 15.5 17.5 
1 IL-lp 44.5 14.9 19.1 26.8 32.4 30.3 32.1 30.6 21.6 20.4 
2 IL-lRtI 9.3 5.9 9.6 15.4 21.2 21.2 3.7 5.5 21.6 16.8 
3 IL-lR tII 32.9 17.7 13.9 21.0 29.1 19.6 13.8 4.9 4.1 3.8 
4 IL-2Ra 54.6 21.6 21.6 54.3 63.6 17.8 19.0 17.2 7.4 4.2 
5 IL-3R(AIC2A) 16.4 16.8 20.4 25.0 34.6 46.5 39.1 33.3 27.0 24.3 
6 IL-3R(AIC2B) 5.1 8.3 15.9 16.1 16.6 22.3 22.8 18.5 15.5 9.0 
7 LIF 56.1 22.8 25.5 32.1 38.7 10.8 20.5 17.3 18.0 17.3 
8 LIFR-1 15.5 9.3 16.5 22.8 22.0 12.2 16.8 18.2 18.8 22.8 
9 LIFR-s 27.8 21.6 27.8 29.4 27.8 24.8 27.4 27.6 29.2 32.6 
10 gpl30 13.5 14.4 14.1 16.3 14.7 10.0 9.6 11.2 11.4 10.4 
11 SCF-1 23.2 19.6 21.8 27.4 26.8 6.2 8.8 10.8 12.6 10.0 
12 SCF-s 26.8 22.4 23.4 29.9 32.8 4.4 7.4 9.2 10.2 13.0 
13 c-kit 7.4 3.0 3.9 10.6 12.1 11.6 3.8 3.4 3.2 3.0 
14 CNTF 24.0 21.6 24.6 23.4 23.4 18.6 17.0 12.2 7.2 6.4 
15 M-CSF 9.3 9.3 13.8 18.9 19.2 3.6 15.2 13.0 17.2 15.4 
16 c-fms 33.2 11.6 35.2 40.9 40.5 9.4 12.8 12.8 18.4 17.8 
17 TGF-P 25.2 25.2 32.4 32.4 33.9 8.6 8.6 7.2 8.0 8.8 
18 TNF-oc 6.2 2.8 6.6 13.6 17.4 3.7 2.8 2.6 2.2 2.3 
Table 2.3 The adjusted volume (OD x mm^) of hybridization signal dots at a 
particular PCR cycle number where prominent trend was observed 
(before saturation phase ofPCR). 
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The dot blotting results were summarized in the following table: 
No. Gene Embryo (7.5 - 17.5 d.p.c.) Placenta (7.5 - 17.5 d.p.c.) 
1 IL-ip down-regulated from 7.5 onwards gradually decreased 
2 IL-lR tI up-regulated from 9.5 onwards down-regulated at 9.5 and 11.5 
3 IL-lR tII down-regulated from 7.5 onwards gradually decreased 
4 IL-2Ra down-regulated at 9.5 and 11.5 gradually decreased 
5 IL-3R(AIC2A) gradually increased gradually decreased 
6 IL-3R(AIC2B) gradually increased gradually decreased 
7 LIF down-regulated from 7.5 onwards up-regulated at 9.5, then decreased 
8 LIFR-1 fairly constant, but weak at 9.5 mildly increased 
9 LIFR-s fairly constant, but weak at 9.5 fairly constant 
10 gpl30 fairly constant fairly constant 
11 SCF-1 gradually increased gradually increased 
12 SCF-s gradually increased gradually increased 
13 c-kit down-regulated at 9.5,then increased gradually decreased 
14 CNTF fairly constant gradually decreased 
15 M-CSF gradually increased constant but weak at 7.5 
16 c-fms down-regulated at 9.5,then increased gradually increased 
17 TGF-P gradually increased fairly constant 
18 TNF-a down-regulated at 9.5,then increased fairly constant 
Table 2.4 The pattem of cytokine expression in embryo and placenta from 7.5 to 
17.5 d.p.c. as summarized from the results of dot-blot hybridization 
(Figure 2.10-2.19). 
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c. The expression pattern in embryo vs placenta 
Both IL-la and IL-lp will bind to IL-lR tI and IL-lR tII, however, IL-la was 
not found in all stages of embryos under investigation. Whereas IL-ip was detected to 
be down-regulated from 7.5 d.p.c. onwards. Type II IL-lR had the same pattem with 
IL-lp while type I receptor conversely showed an up-regulation from 9.5 to 17.5 d.p.c.. 
In placenta, IL-ip and IL-lR tII also down-regulated as in embryo tissue. 
However, IL-lR tI was up-regulated at 15.5 and 17.5 d.p.c. but down-regulated at 9.5 
and 11.5 d.p.c.. 
Although IL-2 and IL-3 were absent from all embryonic tissue, their receptors 
were interestingly present. IL-2Ra was specially down-regulated in 9.5 and 11.5 d.p.c. 
among the 5 time-points. The gene transcripts of IL-3R(AIC2A) and IL-3R(AIC2B) 
showed a gradual increase as the embryo grew from 7.5 to 17.5 d.p.c.. 
In placenta, there was a descending trend of IL-2Ra expression. The pattems of 
IL-3R(AIC2A) and IL-3R(AIC2B) in embryo and in placenta were just opposite. The 
amount of the two receptor subunits increased in embryo while decreased in placenta as 
time of gestation grew. 
LIF which can inhibit embryonic stem cell differentiation was down-regulated 
in embryos from 7.5 d.p.c. onwards, especially at 9.5 and 11.5 d.p.c.. The levels of its 
receptors, both soluble and transmembrane forms, were fairly constant among the 5 
points except a small drop at 9.5 d.p.c.. The signal transduction subunit for LIF, gpl30, 
Chapter 2 Cytokine gene expression during mouse embryonic development 101 
displayed a consistent level throughout the developmental stages. Although CNTF is 
grouped under the same cytokine subfamily with LIF, it did not demonstrate down-
regulation but expressed at constant level instead. 
In placenta, there was a up flush of LIF at 9.5 d.p.c. and then the amount 
decreased onwards. Similar to the trend in embryo, the level of LIFR-1, LIFR-s and 
gpl30 were fairly constant. CNTF, however, exhibited a decrease in placental tissue. 
In embryo, the amount of SCF-1, SCF-s and M-CSF transcripts increased from 
7.5 to 17.5 d.p.c.. However, their respective receptor, c-kit and c-fms did not exhibit 
similar ascending trend but down-regulated specially at time point 9.5 d.p.c.. Like SCF 
and M-CSF, TGF-p and TNF-a also up-regulated from 9.5 d.p.c. onwards. 
In placenta, both SCF-1 and SCF-s levels also showed a gradual increase, 
similar to the trend in embryo. For c-kit, its level gradually decreased from 7.5 to 17.5 , 
d.p.c.. The amount ofM-CSF, TGF-P and TNF-a transcripts remained fairly constant 
in placenta. It is worth to note that the expression level of TNF-a mRNA was very 
low in the placental tissue when compared with that in the embryo. 
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2.5 Discussion 
2.5.1 Isolation of embryo RNA by guanidinium thiocyanate/ cesium 
chloride centrifugation 
Many methodologies have been empirically derived to accomplish the expedient 
isolation of RNA. The most common techniques include the use of guanidinium 
buffers, phenol, SDS, ethanol precipitation or CsCl gradient centrifugation. No matter 
which approach is chosen, three criteria have to be achieved in order to purify high 
quality and undegraded RNA from cells and tissues. They are (1) inhibition of 
endogenous nucleases, (2) deproteinization of the RNA, and (3) physical separation of 
the RNA from the other components of the homogenate (MacDonald et al., 1987). 
In the present project, guanidinium thiocyanate / cesium chloride centrifugation 
is the method of choice for preparing embryo RNA. Guanidinium thiocyanate (GT), 
which is a strong protein denaturant, not only effectively deproteinize sample tissues 
but also eliminate nucleolytic activities. Due to the extremely chaotropic nature of GT, 
it is the best way to deal with recalcitrant RNases with GT lysis buffer. In the cases of 
intractable tissues, or very dilute RNA solutions, ultracentrifugation through CsCl 
gradient to separate RNA from other components is recommended for quantitative 
recovery of RNA. To do a detailed screening of cytokine expression profile, large 
amount of RNA have to be prepared. Therefore, the choice of protocol for RNA 
preparation is important here. 
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Mouse embryos at different stages vary in their size. For 7.5 d.p.c. embryo, 
they are so tiny that only limited quantity of RNA is available from each individual. 
On the contrary, older embryos (15.5 and 17.5 d.p.c.) are large enough to provide 
sufficient RNA, but the developed embryos contain lots of intractable tissues such as 
ligament and cartilage. For these reasons, an effective method for RNA isolation is 
essential. Although GT/ CsCl gradient requires an ovemight centrifugation in an 
ultracentrifuge (18 hrs), it is still worthwhile to adopt this approach which reproducibly 
yields the highest quality RNA sample. 
In order to increase the accuracy of the result, two batches of embryo RNAs 
were taken from two separate groups of pregnant mice. All the experimental 
procedures were repeated for the second batch of mouse embryo RNA of each 
selected stage. Consistency of the data collected from the two batches of sample RNA 
in two independent experiments can diminish the possibility of experimental error. 
2.5.2 mRNA Quantitation 
Since cytokines regulate cell growth and differentiation, their expression level 
may change as the embryo grows. In order to figure out a picture of cytokine 
expression profile along the time axis of mouse development, the amount of interested 
cytokine mRNA in each embryonic stage has to be determined. Northern blot, S1 
nucleases assays, RNase protection and in situ hybridization methods are currently 
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used for analyzing RNA levels, however, they require large quantities of RNA and are 
not very sensitive for quantitative use in detecting low abundance mRNA. 
Furthermore, these methods are time consuming, technically difficult and not suitable 
for a simultaneous processing of a large number of samples. 
PCR has been adapted to amplify specific mRNA sequences after a first step of 
reverse transcription. This not only permits the detection of low abundance mRNAs, 
but also the development of a number of quantitative procedures for the analysis of 
RNA levels (Chelly and Kahn, 1994). 
Quantitative PCR is made complicated by two inherent features of in vitro 
amplification. One is the exponential phase of reaction in which minute differences in 
variables (e.g. concentration of enzyme, templates, primers) can greatly influence the 
PCR product yield. The other feature of PCR is the plateau phase where the reaction 
rate declines dramatically as a consequence of reaction component consumption and 
generation of inhibitors such as pyrophosphates, final PCR products (Kohler, 1995; 
Siebert, 1993). Therefore, most researchers use intemal standards to eliminate tube-to-
tube variations and to determine absolute values of mRNA. 
Two types of intemal standard can be used. One is endogenous sequence or 
gene transcript known to be present at constant levels throughout a series of samples. 
They are typically housekeeping gene, such as p-actin (Kinoshita et al” 1994), p?-
microglobulin (Murphy et al., 1990) and GAPDH (Scheuermann and Bauer, 1993). 
The other type is an exogenous fragment added to the target sample and amplified 
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simultaneously with the target transcript in a single PCR reaction mixture. These 
standards that share the same primer annealing sequences with the target allow 
calculation ofthe absolute amount of target mRNA, as described by Wang et al. (1989). 
Each type of internal control has advantages and limitations. However, most problems 
can be circumvented by using competitive PCR in which an exogenous template having 
identical primer binding sites as target is co-amplified in a competitive fashion (Siebert, 
1993). 
Semi-quantitative PCR 
In many situations, it is sufficient to compare the relative amounts of a 
particular target sequence in different samples but not necessary to determine the actual 
number of starting target molecules. A simpler approach named as ‘semi-quantitative 
PCR' can be adopted for this purpose (Dallman and Porter, 1991). The essence of this 
approach is to sample product from PCR at multiple points throughout the 
amplification process. It is actually a kinetic analysis in which the amount of amplified 
products are plotted against cycle numbers. If the data are collected before the plateau 
phase is reached, the difference in the amount of amplified products is equal to the 
difference in the abundance of that particular transcript in the starting materials. 
The aim of this part of thesis is to determine the expression pattem of various 
cytokine genes during embryonic development. It is, therefore, not necessary to work 
out the exact number of interested mRNA. Semi-quantitative PCR is sufficient to 
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accomplish this objective. A comparison of the level of cytokine mRNA in different 
embryonic stages (7.5, 9.5, 11.5, 15.5 and 17.5 d.p.c.) has been performed using this 
approach. This method has the advantage of simplicity and is readily be applied to any 
previously defined PCR conditions making it easily accessible to the analysis of 
different target sequences. 
2.5.3 Cytokine mRNA phenotyping by RT-PCR 
a. Reverse Transcription 
Reverse transcription (RT) might be primed by using a specific antisense primer 
for the gene of interest, random hexanucleotide primers, or oligo d(T). The latter 
approach is most consistent and results in the highest amplification of target sequence. 
Besides, the use of Oligo d(T) in cDNA synthesis also produces same sample for the 
amplification of any desired target transcripts. Therefore, Oligo d(T) 2^.is was chosen 
as the RT primer in the present project. 
For the relative quantitation method, cDNAs to be compared after PCR were 
synthesized in parallel using the same reaction mix, so as to improve the accuracy. 
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b. GAPDH as a control for normalization 
In all the RT-PCR experiment, glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) was regularly used to judge the success of RNA preparations with regard to 
degradation of RNA and efficacy of reverse transcription. To perform relative 
quantitation of specific transcripts, the prerequisite is to demonstrate that each sample 
has undergone equivalent reverse transcription to cDNA and equivalent amplification 
in the PCR, in other words, to normalize all the samples. GAPDH is a metabolic 
enzyme known to be present at constant level in various cell types. Normalization was 
therefore done by using a pair of primer specific to this enzyme gene transcript. 
Samples were said to be normalized when there was no greater than 2-fold difference in 
the band intensity of GAPDH PCR product among the 5 embryonic RNA samples, as 
resolved on agarose gel. Comparative data of cytokine gene expression was collected 
and validated only after the RT samples were equalized by GAPDH control. Since the 
control sequence is not being used to define absolute levels of mRNA, differences in 
primer efficiencies between the control and test primers are not important. 
Figure 2.5 shows one of the gel photos in which the intensities of GAPDH 
bands amplified from the 5 RNA samples did not have more than 2-fold difference 
from each other. Regularly, normalization was performed by subjecting equal amount 
ofRT product from each embryonic stage to PCR for 25 cycles where the reaction had 
not reached the plateau phase yet. In cases when difference in the band intensity was 
detected, volume of RT for PCR were adjusted accordingly so as to attain 
Chapter 2 Cytokine gene expression during mouse embryonic development 101 
normalization among the 5 samples. GAPDH control was always included in all the 
experiments of comparative purpose, in order to eliminate day-to-day and tube-to-tube 
variations. 
c. PCR for cytokine transcripts 
One prerequisite for the detection of gene transcripts by PCR method is the use 
of a pair of specific and efficient primer. Most literatured and well studied cytokine 
genes in mouse have already been sequenced and the sequence information is available 
from special databases via data networks. With the sequences on hand, primer search 
was started with the aid of an automated primer search software, OLIGO 3.4 Primer 
Analysis Software. Although there is a general set of rules for primer design (as listed 
in Section 2.1.2 ), it cannot ensure the synthesis of an effective primer pair. As a matter 
of fact, the selection is somewhat empirical. Fortunately, the primers used in this 
project were tested to work satisfactorily. They were designed to be situated on two 
different exons and spanning at least one intron to allow unambiguous discrimination 
between cDNA and unwelcome genomic amplification products. The products were 
further analyzed by hybridizing with an intemal probe that lies within the target 
sequence between the two original primers. 
Thirty genes of cytokines and cytokine receptors were studied for their pattem 
of expression in both the embryo and the placenta during development from 7.5 to 17.5 
d.p.c. The first step was to perform a qualitative test to check the presence of 
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transcripts. It was done by 50 cycles ofPCP. using specific primers. After this number 
of amplification cycles, even low abundance RNA could easily be detected on the 
agarose gel. It was always established by gel electrophoresis that under the conditions 
used the PCR resulted in a single product of the expected size. No banding means the 
absence of that particular transcript in the RNA sample. 
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2.5.4 Cytokines and receptors in embryonic development 
During embryogenesis, cell-to-cell interactions are one of the principal 
mechanisms by which differentiation, morphogenesis, and growth are regulated. As 
cytokines are associated with intercellular communication, these molecules must play 
crucial roles in mastering the development of embryos. In order to determine the in 
vivo embryonic role of cytokines, the first step is to determine when and where they are 
expressed during the life cycle of the mouse. In the first part of the thesis, the 
expression patterns of 30 cytokines and cytokine receptors during mid- to late-gestation 
(7.5 to 17.5 d.p.c.) of ICR mouse were investigated using reverse transcription and 
semi-quantitative PCR. 
RT-PCR allows detection of transcripts of low copy number in embryos, 
obviating the need to obtain large amounts of embryonic tissue required for standard 
RNA analysis. Since it was not necessary to work out the exact amount of cytokine 
transcripts, a simpler and time-saving method, semi-quantitative PCR, was adopted to 
determine the relative levels of cytokine mRNA in different stages of mouse embryo. 
The results revealed that more than half of the investigated cytokines and receptors had 
regulatory patterns among the 5 developmental stages, underlying certain biological 
functions in regulating proper embryonic development. 
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2.5.4,1 Cytokines in hematopoietic development of mouse fetus 
In mouse, the formation ofblood cells, or hematopoiesis, begins in the yolk sac 
at approximately day 7 of embryogenesis. The major site ofhematopoiesis shifts to the 
fetal liver by day 10 of gestation and finally to the bone marrow, which remains the 
major hematopoietic organ in the adult (Moore and Metcalf, 1970). 
Some cytokines have been shown to be important to hematopoietic 
development, such as IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, GM-CSF, G-CSF, M-CSF and 
its receptor c-fms, SCF and its receptor c-kit ^N[akayama et al., 1989; Murray et al., 
1990; Schmitt et al., 1991; Heike et al., 1994). These factors range from being lineage 
specific, such as M-CSF (Stanley and Heard, 1977) and G-CSF OSficola et al., 1983)，to 
acting on multiple lineages, such as IL-3 and GM-CSF (Metcalf et al., 1980; Iscove and 
Roitsch, 1985). 
G-CSF, GM-CSF and IL-3 
Studies of hematopoietic regulatory molecules in embryonic development have 
typically focused at stages before implantation, prior to the onset ofhematopoiesis. For 
example, transcripts of IL-lp (Rothstein et al., 1992) and IL-6 (Murray et aL, 1990) 
were detected in mouse blastocysts at 3.5 days of gestation while the mRNAs of IL-4, 
IL-6, SCF and c-kit were found during murine embryonic stem (ES) cells 
differentiation (Schmitt et al., 1991). Although G-CSF, GM-CSF and IL-3 were well 
documented to be important factors in adult hematopoiesis, their expression could not 
be detected in 3.5 d.p.c. blastocysts or during ES cell differentiation (Rappolee et al., 
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1988; Schmitt et al., 1991). Their absence from early stages mouse embryo supports 
the hypothesis that G-CSF, GM-CSF and IL-3 are not critical to early hematopoiesis in 
fetus. 
The situation in mid-late mouse embryos was revealed by the present study. 
The expression trend of the above mentioned hematopoietic cytokines was determined 
from 7.5 d.p.c. onwards, during which hematopoiesis should have occurred in the fetus. 
After RT-PCR, no signals for G-CSF, GM-CSF and IL-3 transcripts were obtained in 
embryos aged from 7.5 d.p.c. to 17.5 d.p.c.. The results are consistent with those of 
Kohchi's study (1994) in which no GM-CSF and IL-3 mRNAs were detected in mouse 
embryo from 10 to 17 d.p.c.. Although these 3 cytokines are recognized as important 
regulators of hematopoiesis in adult animal, they were totally absent from early 
blastocyst stage to late embryos. This finding further strengthens the hypothesis that G-
CSF, GM-CSF and IL-3 are actually not essential in fetal hematopoiesis or 
development. 
SCF and c-kit 
SCF together with its receptor {c-kit) have been reported to have IL-3 like 
activities on hematopoietic CFUs (Anderson et al., 1990; Martin et al., 1990), and it is 
possible that they may have a similar function in hematopoiesis. SCF and c-kit were 
expressed through blastocyst stage to late developmental stages. Their presence 
implies a regulatory effect on embryonic development, properly substituting for IL-3 
acting on multiple lineages. Alternative splicing gives rise to two types of SCF mRNA, 
SCF-1 and SCF-s. Both of them encode a transmembrane domain. However, the long 
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form SCF (SCF-1) carries a proteolytic cleavage site which probably results into the 
soluble form of SCF (Flanagan et aL, 1991). Both types of SCF mRNA showed a 
gradual increase in quantity as the time of gestation grew, implying an increasing 
importance of activities mediated by SCF and its receptor, c-kit. 
IL-la, IL-ip and their receptors 
As mentioned in previous section, IL-1 through IL-6 are important regulators of 
hematopoiesis in adult mammals. However, none of their transcripts were detected in 
the mouse embryos aged from mid- to late-gestation, except that ofIL-ip. 
IL-la and IL-ip are the members of the IL-1 gene family. In general, they 
induce the same biological effects in a wide variety of immune and inflammatory 
responses. Their activities are mediated by the interaction with specific membrane 
receptors on the surface of target cells. Two types ofIL-1 receptor (I and II) have been 
reported. Both types can bind with IL-la or IL-lp, but with different preferences. 
Type II receptor (IL-lR tII) serves as a decoy receptor. By binding IL-1, the IL-lR tII 
can shunt the ligand away from IL-lR tI. Thus, increased expression ofIL-lR tII may 
be a way to reduce the biological effects ofIL-1. Because IL-lR tII binds preferentially 
to IL-ip, this type II receptor likely serves as a natural antagonist ofIL-ip (Dinarello, 
1994). 
Using RT-PCR, amount ofIL-ip transcript together with that ofIL-lR tII were 
found to be down-regulated after 7.5 d.p.c.. IL-lR tI mRNA, on the other hand, 
increased as embryo grew. Previous studies indicated that IL-lR tI is found on nearly 
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all cell types while IL-lR tII is found on the surface of limited cell types (Dinarello, 
1994). Expression of IL-lR tI more likely affects the biological responses to IL-1 
since this type of receptor molecules is more able to transduce signals. Although IL-ip 
down-regulated, the increasing expression ofIL-lR tI reflected the biological functions 
ofIL-1 was still effective in the growing embryos. 
IL-2 and receptor 
IL-2 has been widely recognized as a cytokine that plays a crucial role in 
regulation of the immune response by exerting multiple biological activities on target 
cells. The best characterized activity of IL-2 is the promotion of clonal expansion of T 
cells (Kono et al., 1990). There are 3 classes of IL-2R (a,P,y) exist. IL-2Ra alone 
constitutes to the low affinity IL-2R. High affinity receptor necessarily contains all 3 
component chains, IL-2Ra, P and y (Cao et al., 1993). Due to unavailability of primers 
specific to IL-2Rp and y, only the expression level of IL-2Ra was checked in this 
study. IL-2 transcript could not be detected but one of its receptor chain IL-2Ra was 
surprisingly present. Although its level of expression was low, the biological 
significance of their presence without the ligand is as yet unknown. This kind of 
situation was not rare and happened to another interleukin, IL-3. 
IL-3 and receptor 
IL-3, also known as a multi-colony stimulating factor is potent growth factor 
stimulating the development of various lineages ofhematopbietic cells. The mouse IL-
3 receptor (IL-3R) is composed of an IL-3Ra and a common P subunit which is shared 
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by IL-3, GM-CSF and IL-5 receptors. Two distinct but related genes, AIC2A and 
AIC2B both encode the p subunit of IL-3R (Hara and Miyajima, 1992). The 
expression ofIL-3R(AIC2A) and IL-3R(AIC2B) were detected in embryonic tissues of 
the 5 developmental stages and in an increasing trend. Result for IL-3 transcript, in 
contrast to its receptor subunit, was negative. Similar to the case of IL-2 , expression of 
receptor unit was observed even if the ligand was not present. The significance of such 
phenomenon remains unclear but is speculated that expression of receptor is for other 
unknown ligand that has not been discovered yet. 
IL-4 and IL-6 
IL-6 may play an important role in vivo in the expression of multiple lineages 
during fetal development, both by inducing non-cycling cells to become responsive to 
other cytokines and acting itself to support clonal proliferation and maturation of 
different lineages (Lee, 1992). Similarly, IL-4 also acts on various lineages of 
hematopoietic cells, such as lymphocytes, mast cells and basophils (Paul and Ohara, 
1987). In this regard, IL-6 in combination with IL-4 stimulate colony formation of 
various hematopoietic progenitor cells (Rennick et al., 1989). The expression of IL-4 
and IL-6 were observed in blastocyst and ES cells (Murray et al., 1990; Schmitt et al., 
1991)，however, they were not detected in the mid to late stages (7.5 - 17.5 d.p.c.) of 
embryos (present study). The early expression of IL-4 and IL-6 implies their 
synergistic effects on very primitive hematopoietic cells and the effects stop at least 
from the onset ofhematopoiesis (7.5 d.p.c.). 
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IL-5 
In adult, IL-5 is a lineage specific cytokine which stimulates eosinophil colony 
formation and activates mature eosinophils. No studies have been reported for the 
expression patterns of IL-5 in developing embryos, therefore, its embryonic role is as 
yet unknown. Our results showed that the transcript of IL-5 was absent from embryo 
tissue of all gestational ages. It was therefore conceivable that IL-5 is not crucial in 
fetal hematopoiesis and that IL-5 is necessary only in times ofhematopoietic crisis. 
IL-10 and IL-11 
The cytokine interleukin-10 (IL-10) was initially described as cytokine 
synthesis inhibitory factor, a product of mouse T helper 2 (Th2) clones which inhibited 
cytokine synthesis of Thl clones (Fiorentino et al., 1989). There were evidence 
indicating that IL-10 also supports the growth of hematopoietic progenitor cells, 
however, its potential to stimulate these cells is determined by the presence of other 
cytokines, like IL-3, IL-6 and G-CSF (van Vlasselaer, 1995). Due to this dependence, 
it is fair to assume that IL-10 acts via an indirect pathway. Similar to IL-10, IL-11 also 
has to act in synergy with other cytokines. For example, it supports the growth and 
development of primitive multipotent progenitors as well as cells committed to the 
megakaryocytic lineage only in the presence of SCF and IL-3 (Musashi et al., 1991). 
Result of RT-PCR showed that neither transcript of IL-10 nor that of IL-11 was 
detected in any embryo tissues under investigation. These findings indicated that they 
were not essential or indispensable in embryonic development, probably because of 
their indirect and uncritical activities. 
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M-CSF and c-fms 
The c-fms gene encodes the cell surface receptor of the growth factor M-CSF 
(Sherr et al., 1985), and is expressed by cells of the monocyte-macrophage lineage in 
the hematopoietic system of the adult animal (Rettenmeier et al., 1986). The 
interaction of M-CSF with its receptor, c-fms, is required for the differentiation of cells 
in this lineage. The present study showed that the expression level of this ligand and 
receptor pair in mouse embryo simultaneously increased as time of gestation increased. 
The coexpression of receptor and ligand suggests that M-CSF plays a role in the 
development and differentiation of macrophage lineage within the embryo. Using in 
situ hybridization, Regenstreif and Rossant (1989) detected the transcripts of M-CSF 
and c-fms in uterine epithelium and matemal decidua from 7.5 to 8.5 days of gestation. 
The fetally derived c-fms mRNA was observed only from 9.5 days onward in 
trophoblast cells while the level o fM-CSF transcript in fetus was much lower than that 
in uterine epithelium at all later steps examined. The time course and spatial pattem of 
expression of these two genes suggest that the interactions between c-fms and its ligand 
M-CSF are unlikely to be important in directing events within the embryo itself until 
9.5 d.p.c. when c-fms expression first appeared in embryos (Regenstreif and Rossant, 
1989). 
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LIF and its transducer subunit gpl30 
LIF is a pleiotropic cytokine with the ability to maintain the developmental 
potential of pluripotent embryonic stem cells. Previous studies have revealed its 
expression in 3.5 d.p.c. blastocysts (Conquet and Brulet, 1990; Murray et al., 1990) and 
uterus during the first 5 days of pregnancy (Bhatt et al., 1988). Subsequent in vivo 
studies discovered that one of this protein's most important functions is to regulate 
implantation of the embryo by both priming the uterus and possibly regulating cell 
proliferation in the blastocyst (Stewart, 1994). 
LIF gene transcription is discernible in the extraembryonic ectoderm of 7.5 
d.p.c. embryos, and in the placenta of 9.5，10.5 and 12.5 days of gestation (Conquet and 
Brulet, 1990). In this study, LIF mRNA was detected in all embryos aged from mid- to 
late gestation (7.5 to 17.5 d.p.c.)，though with a down-regulating trend. Its continued 
presence throughout gestation further implicates this molecule in embryogenesis. 
Moreover, differential expression of LIF transcript is further modulated by other 
cytokines such as I L - l a , IL-lp, TGF-p and bFGF (Kurzrock et al., 1991)，a 
phenomenon that may be responsible for fine-tuning control of LIF actions in different 
physiological situations. 
LIF receptor (LIFR) belongs to hematopoietin receptor family which can be 
generated as secreted extracellular proteins via alternative splicing (Mosley et al., 
1989). The long form LIFR cDNA includes a stop codon ahead of the transmembrane 
and cytosolic domains and thus encoding soluble form of LIF receptor molecules. 
Secreted receptors can act as natural antagonists of cytokine action by directly 
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competing for ligand with transmembrane receptor and/or by promoting the systemic 
clearance of secreted cytokines (Goodwin et al., 1990). In this manner, soluble form of 
LLFR could be an important determinant of embryonic differentiation. Long form and 
short form o f L I F R mRNA appeared to express at fairly constant level in the embryonic 
tissue along the 5 developmental stages, however, the level of membrane bound form 
(LIFR-s) was generally lower than that of its secreted counterparts. 
The physiological effect initiated by LIF is, therefore, not only adjusted by its 
production but also by the presence of natural antagonist (soluble receptor) and specific 
regulators such as IL-1, TGF-P and bFGF. 
gpl30 is a ubiquitously expressed signal-transducing receptor component 
shared by LIF, IL-6, IL-11, CNTF, OSM and cardiotrophin-1 (Kishimoto et cd., 1996). 
The discovery of this shared signal transducer helps to explain how these different 
cytokines mediate overlapping biological functions. The present study revealed that the 
levels of gpl30 transcript were fairly constant through 7.5 to 17.5 d.p.c., both in 
embryo and placenta. Yoshida and his co-workers (1996) provided evidence for the 
fact that gpl30 is essential in embryonic development. They created mice deficient in 
gpl30 by targeted disruption of the gene and found that embryos homozygous for the 
mutation progressively died between 12.5 d.p.c. and term. The knockout mice 
experiment reflects the importance of this signal transducer in development. 
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2.5.4.2 Other cytokines 
TGF-P 
TGF-p is a family of polypeptides that regulate cell growth and differentiation. 
It is now apparent that at least five genetically distinct forms of TGF-P exit. In this 
study, it was the transcript of TGF-pi , which is the most predominant isoform, being 
investigated. Its mRNA was detected in mouse embryos from day 7.5 onwards with a 
gradual increasing quantity. This finding is consistent with the results of other previous 
studies, in which TGF-pi mRNA or protein was also observed from mid- to late 
gestation (Heine et aL, 1987; Lehnert and Akhurst, 1988). Expression of TGF-pi in 
defined temporal pattem during mouse development reflects its distinct role in fetal 
development. The inactivation of the mouse TGF-pi gene has been shown to result in 
a wasting syndrome with diffuse inflammatory infiltrates in homozygous animals 
which died before or right after birth (Kulkami et al., 1993). Lack of this cytokine is 
therefore detrimental to mouse. 
TNF-a and TNF-P 
These two cytokines are multifunctional and implicated in diverse processes, 
including acute inflammation, angiogenesis, blood cell differentiation, cell proliferation 
and cell killing. Since TNF-a is defined to be a molecule orchestrating inflammation in 
adult, it was then hypothesized that the major roles of TNF-a in embryonic 
development are to induce a state of so-called ‘ontogenic inflammation' (Yamasu et al,, 
1989)，which is an essential pre-requisite for normal embryonic development. Kohchi 
and co-workers (1994) demonstrated that both TNF-a and TNF_P were expressed 
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constitutively in almost all organs of fetus as well as the placenta from 10th day of 
gestation and onwards. He then postulated that both TNF-a and TNF-P are molecules 
involved in ‘ontogenic inflammation'. The present study also detected the presence of 
TNF-a mRNA from 7.5 to 17.5 d.p.c.. The level of TNF-a down-regulated at 9.5 
d.p.c. but increased afterwards. Evidence provided that either an excess or too little 
amount o f T N F - a might be fatal, therefore its expression has to be fine tuned in a time-
dependent pattem for normal development. In contrast to Kohchi's study, transcript of 
TNF-P could not be detected here. It is therefore speculated that TNF-P may not be 
critical in 'ontogenic inflammation'. Since there is no other report on TNF-P in 
connection with embryonic development, the role of TNF-P in this context remains 
controversial. 
CNTF 
CNTF is a cytokine that promotes the survival of ciliary, sensory and 
sympathetic and motor neurons in vitro (Sendtner et aL, 1994). Stewart and co-workers 
(1994) have been unable to detect CNTF transcripts in the mouse uterus or pre-
implantation embryo. On the other hand, its mRNA was detected in mouse embryos of 
mid- to late gestational ages ^>resent study). CNTF knockout mice were derived and 
were overtly normal during the first postnatal weeks. But with increasing age, spinal 
motor neurons exhibited progressive degeneration which was functionally reflected by 
a significant reduction in muscle strength (Masu et al., 1993). This result has 
demonstrated that expression of CNTF gene is not necessary for the maintenance of 
motor neuron function during embryonic development, but it has an essential role in 
regulating motor neurons in the postnatal period. It seems that the role of CNTF in 
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embryogenesis remains elusive, however, the presence of its transcript in embryonic 
tissue and its ability to maintain the pluripotentiality o f E S cells (Conover et al., 1993) 
suggest a functional role of CNTF in mammalian development. 
IFN-y 
IFN-y has potent inununoregulatory effects on a variety of cells including 
activation of macrophages, increase in natural killer cell activity, up-regulation of 
antibody secretion, etc. It is clear that IFN-y plays important role in the immune 
system but what role does it play in embryonic development? Rothstein et al. (1992) 
found the expression of IFN-y in blastocyst of mouse embryo. It was shown in this 
experiment, however, that the expression of this cytokine could not be detected in 
embryos aged from 7.5 to 17.5 d.p.c.. This result is identical to the finding by Kohchi 
and his co-workers (1994)，in which IFN-y transcript could not be found in mouse 
embryos ofmid-late gestation (10 to 17 d.p.c.). Therefore, the expression ofIFN-y was 
not constitutive throughout development, but only occurs transiently during early 
embryogenesis and stops at least from 7.5 d.p.c. onwards. The teleological meaning of 
this transient expression ofIFN-y awaits further experimentation. 
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2.5.5 Expression Pattern in placenta: maternal and fetal communication 
Cytokines have key roles in fetal-matemal relationships during pregnancy. 
Cytokine expressed mainly in matemal tissues would have the task of preparing a good 
environment for the embryo, whereas cytokines expressed in embryo could function for 
the embryo's own development. The supply of matemal cytokines would become less 
substantial and influential as the embryo could generate such molecules by itself. As 
observed from the expression profile of cytokines in placenta, most of them were 
gradually down-regulated as embryo developed and grew. Exception was also 
obtained, in which SCF-1, SCF-s and c-fms transcripts showed an increasing amount in 
placenta as gestation period prolonged, similar to the trend observed in embryos. 
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Chapter 3 
Molecular analysis of mouse Oncostatin M 
3.1 Introduction 
Human OSM gene had been cloned and sequenced early in 1989. However, the 
mouse OSM gene is not studied up to date. According to gene structure, primary 
amino acid sequence, biological functions and receptor binding, OSM is grouped into a 
cytokine subfamily named as neuropoietic family. The group also includes LIF, CNTF, 
IL-6 and IL-11. Among the members, OSM is more closely related to LEF. In view of 
LEF, the human and mouse clone have a high homology of nearly 90%. A similar high 
homology is predicted for OSM gene. Therefore, it is reasonable to use human OSM 
exon fragments to fish out the mouse clone. 
The aim of this part of the project is to perform molecular analysis of the murine 
OSM gene. The result may facilitate further studies on this cytokine using mouse 
model. 
The analysis procedures for this part of the thesis was summarized in Figure 
3.1. As the gene sequence of human OSM was documented, two pairs of primer were 
specially designed to clone two different exon fragments by using PCR method. Their 
priming sites were schematically represented in Figure 3.2. The first pair of the 
primers flanked exon 2 with a product size of 121 bp while the other pair flanked 
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exon 3 coding region and gave a fragment of 591 bp in length. The PCR products 
were then subcloned into vector for manipulation. The identity of the subcloned 
fragments were directly verified by sequencing. After labeling the purified hOSM exon 
2 and exon 3 fragments, Southem hybridization against mouse genomic DNAs was 
performed separately. Human genomic DNA was also Southem hybridized in parallel 
as a control experiment. 
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P C R cloning o f h u m a n O S M exon 2 and exon 3 
• 
Subcloning o f h u m a n O S M exon 2 and exon 3 into p U C 18 
Purified PCR products of pUC 18 DNA 
exons 2 and 3 fragments + 
T4 DNA polymerase Tilling in, ^ f ^ ^ , digestion 
^ , ^ , r � ® CBlunt-end reaction) 
(Blunt-end reaction) 
exon 2 exon 3 pUC 18 
Resolved in agarose gel 
I 
DNA recovery from gel 
I 
Ligation (insert: vector = 5:1) 
Transformation 
i 
Screening of recombinants 
• 
Verif icat ion of the clones o f h u m a n OSM exons 2 and 3 by cycle sequencing 
• 
Purif icat ion of human O S M exons from plasmid for probe making 
+ 
Southern hybridization against mouse genomic D N A 
Figure 3.1 Flowchart of the analysis procedures for mouse OSM gene. 
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P 1 _ P 3 _ 
^m MiMW#ffPf| MpMM^^^^^MM 一 一 1 
H^ H^ ^^ ^^ ¾^ ^^ ^ m^ i^ ^^ ^^ ^^ ^^ m^ ^^ ^^ ^^ ^^ ^^ g ^ ^^ ^^ ^^ ^^  ^^H ^^M ^^ ^^ j^ 
_ P 2 _ P 4 
h O S M e x o n ‘ •• … 
Figure 3.2 The priming sites of the two pairs of specially designed primers for 
human OSM exon 2 and exon 3 fragments. P1 and P2 flanked a 
fragment 121 bp in length while P3 and P4 amplified a 591 bp-fragment. 
The unfilled portion of exon III represents the 3’ non-coding region. 
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3.2 Materials 
3.2.1 Chemicals and Reagents 
Ampicillin Sigma (No. A-9518) 
Ammonium acetate f ^ ^ O A c ) Sigma fNo. A-8750) 
5-Bromo-4-chloro-3-indolyl-P-D galactoside (X-gal) Sigma Q<\o. B-4252) 
Cetyltrimethylammonium bromide (CTAB) Sigma fNo. H-5882) 
Chloroform Ajax chemicals fNo. 152) 
Dodecyltrimethylammonium bromide (DTAB) Sigma fNo. D-8638) 
Formamide Sigma fNo. F-7503) 
Isoamylalcohol Ajax chemicals (No. 64) 
Isopropyl-p-D-thiogalactoside (IPTG) Sigma (No. I-6758) 
MOPS Sigma (No. M-8899) 
N,N-Dimethylformamide Sigma CNo. D-8654) 
Nick column, Sephadex G50 Pharmaciaps[o.l7-0855-02) 
Phenol Sigma (No. P-3653) 
Polyethylene glycol MW. 8000 (PEG 8000) Sigma CNo. P-2139) 
Redivue [ a - ' 'P] dCTP, 3000 Ci/mmol Amersham C^o. AA 0005) 
Rubidium chloride (RbCl) Sigma C^^ o. R-2252) 
Triton X-100 Fluka OSfo. 93426) 
Tryptone Oxoid (code L42) 
Yeast extract Oxoid (code L21) 
Remark: The water used throughout the experiments was of ultrapure grade. 
3.2.2 Enzymes 
Lysozyme Sigma _ L-6876) 
Proteinase K Sigma Q<io. P-4914) 
T4 DNA ligase (8,500 Weiss units/ml, Pharmacia) 
T4 DNA polymerase (10 U/ \il, Pharmacia) 
Restriction enzymes: Bam H I 50 U/ ^il, Amersham 
EcoRl 12 U/ ^il, Promega 
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EcoR I 60 U/ ^il, Promega 
Pst I 60 U/ ^il, Amersham 
Sma I 12 U/ ^il, Promega 
Hind III 80 U/ ^1, Promega 
RNase ONE 10 U/ ^il, Promega 
3.2.3 Buffers 
Buffer H for EcoR I，1 Ox Promega 
Buffer H for Pst I，1 Ox Amersham 
Buffer J for Sma I, 10x Promega 
Multi-core buffer, 10x Promega 
ONE-PHOR-ALL buffer Pharmacia 
TE buffer : lOmM Tris-HCl (pH 7.5) and lmM EDTA (pK 8.0) 
3.2.4 Solutions 
Ampicillin stock solution 
50 mg/ml stock solution was prepared by dissolving lg of the sodium salt of ampicillin 
in 20 ml H2O. The solution was sterilized by filtration and stored at -20°C. 
CTAB solution 
5% CTAB, 0.4M NaCl 
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DTAB solution 
8% DTAB, 1.5M NaCl, 100mM Tris-HCl pH 8.6, 50mM EDTA 
IPTG solution 
A 0.5M stock solution was prepared by dissolving 1.4 g of IPTG in 10 ml distilled 
water. The solution was sterilized by filtration through a 0.22 ^im membrane and stored 
at -20°C. 
PEG solution 
30% PEG 8000，1.8M NaCl 
Phenol equilibrated with Tris-huffer 
Phenol was equilibrated to a pH > 7.8 before use. Equal volume of Tris-HCl (pH 8.0) 
was added to liquified phenol and mixed well. Aqueous phase was removed after 
equilibration. 
RF1 solution 
RF 1 was composed of O.lM RbCl, 50mM MnCVAI^O，30mM potassium acetate, 
lOmM CaCl2 and 15% (w/v) glycerol. The final pH of the solution was adjusted to 5.8 
with 0.2M acetic acid. Sterilization was done by filtration. 
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RF 2 solution 
RF 2 contained lOmM MOPS, lOmM RbCl, 75mM C a C ^ J ^ O and 15% (w/v) 
glycerol. The final pH was adjusted to pH 6.8 with NaOH (as necessary) and the 
solution was sterilized by filtration. 
STET. 1 solution 
STET.1 solution was made up of 8% sucrose, 50mM EDTA, lOmM Tris-HCl (pH 8) 
and 0.1% Triton X-100. 
X-gal stock solution 
250mg/ml stock solution was prepared by dissolving lg of X-gal in 4 ml N,N-
dimethylformamide (DMF). The stock was stored at -20°C. 
3.2.5 Culture media 
Luria-Bertani (LB) medium 
LB medium contained 10g tryptone, 5g yeast extract and 10g NaCl per liter. It was 
sterilized by autoclaving for 20 min at 151 lb/sq. in. on liquid cycle. 
LB agar 
LB medium added with 15g agar per liter. 
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SOB medium 
One liter of SOB contained 20g tryptone, 5g yeast extract, 0.5g NaCl and 2.5mM KC1. 
The pH was adjusted to 7.5 with NaOH and sterilized by autoclaving. 5ml of a sterile 
solution o f 2 M MgCl2 was added afterwards. 
3.2.6 Competent cell 
D H 5 a was used for making competent cell. Its genotype was F" cj)80d /acZAM15 
A ( / a c Z Y A - a r g F ) U 1 6 9 deoR recA endAl hsdRl7{v^-,m^^) supE44X' thi-l gyrA96 
relAA. 
3.2.7 DNA materials 
1 kb ladder DNA marker (GffiCO/BRL No. 15615-016) 
X Dl<lA/Hind III marker 
Human genomic DNA (Promega No. G 3041) 
Mouse genomic DNAs (Promega No. G 3091) 
Mouse genomic DNAs of BALB/c and C57BL 
pUC 18 
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3.2.8 Pr imers 
Table 3.1 Sequence of primer specific for human OSM exons 2 and 3. 
mRNA sequences (5，to 3，） size of fragment 
(bp) 
upper CAAGGCCTGGATGTTCCTAAAC 
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3.3 Methods 
3.3.1 Primers and internal probes 
Oligonucleotide primers were custom synthesized by Integrated DNA 
Technologies, Inc. The oligonucleotides were purified by gel filtration column and 
obtained as lyophilized powder. 
Upon arrival, powder of primer was first dissolved in 500 jil T E � � buffer and the 
concentration was determined by OD measurement at 260nm according to the 
following formula: 
Concentration of oligonucleotide (pmoV ^1) = OD260 / s x dilution factor x 1000 
where s corresponds to the summation of extinction coefficient of the bases in an 
oligomer. 
( A = 1 1 . 5 , T = 8.8, G = 1 1 . 7 , C = 7.3) 
A working solution of 25 pmoV i^l of each primer was prepared. 
3.3.2 Cloning ofhuman Oncostatin M exon 2 and exon 3 by PCR 
Primer pairs specific for human OSM exon 2 and exon 3 were used to clone the 
exon fragments from the human genome by PCR method. A volume of 20 i^l 
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containing � l ^ i g o f h u m a n genomic DNA was first boiled for 10 min and then quickly 
chilled on ice. The PCR was initiated by adding the boiled DNA template to 30 ^il 
reaction mixture containing 5 p,l of 10x PCR buffer [20mM O^4)2SO4, 75mM Tris-
HCl, pH 9.0 and 0.01% (w/v) Tween], 3 ^1 o f 2 5 mM MgCl2, 1 ^1 of lOmM dNTP mix, 
2 ^il of each corresponding primers (25 pmol/ ^il), 0.5 ^1 of 0.5 U/ ^il of 
ThermoprimePi^ DNA polymerase (Advanced Biotechnologies) and 16.5 |il sterile 
double distilled water. The reaction mixture was then overlaid with mineral oil and 
subjected to amplification using the Temp Tronic thermocycler (Thermolyne Co.). The 
temperature profile was 94°C for 1 min; 56°C for 1 min; 72°C for 1 min, and was 
repeated for 30 or 50 times. 
20 ^il of the PCR products was analyzed by gel electrophoresis in 1.5% 
Synergel-0.7% agarose using lx TAE buffer containing (0.5 ^g/ml) EtBr. After 
electrophoresis, the EtBr-stained DNA bands were visualized and photographed under 
UV illumination. 
3.3.3 Subcloning of human OSM exons 2 and 3 into pUC 18 
a. Preparation ofhuman OSMexons and plasmid 
i) Purification ofPCR products 
Putative human OSM exon 2 and exon 3 cloned by PCR method (10 reactions 
for either primer pair were first pooled into one “ tube) were purified by 
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phenol:chloroform:isoamyl alcohol (25:24:1) extraction. The DNA fragments were 
then precipitated using 0.5 volume of 7.5M NH4OAc and 2.5 volume of absolute 
ethanol. The pellets of exon 2 and exon 3 fragments were resuspended in 50 |il sterile 
water separately. 
ii) T4 DNA polymerase 'blunt-end ‘ reaction for PCR products 
DNA fragments resulted from PCR were blunt-ended by using T4 DNA 
polymerase. The reaction was carried out in a mixture containing 50 p,l of purified 
PCR product, 20 ^il of 5x T4 DNA polymerase buffer (0.165M Tris-acetate pH8.0, 
0.33M potassium acetate, 0.05M magnesium acetate, 2.5mM DTT and 0.5 mg/ml 
bovine serum albumin) and 26 p,l sterile water. The mixture was incubated at 37°C and 
20 U o f T 4 DNA polymerase was added after 5 min of incubation. In not more than 30 
seconds, 2 p,l of lOmM dNTPs was also added to the reaction mixture which was then 
incubated for another 30 min at 2>TC. 
iii) Sma I digestion of p UC18 
The vector, plasmid pUC 18，was digested by Sma I enzyme to create a linear 
fragment with blunt ends. 5 ^ig of pUC 18 was digested by 8 U of Sma I in lx Buffer J 
(Promega) at 25°C for an hour. 
b. Ligation 
Ligation was carried out in an insert to vector ratio of 5:1. The amount of insert 
and vector was estimated by comparing the intensity of band resolved on gel. 
Chapter 3 Molecular analysis of mouse Oncostatin M 130 
Linearized pUC 18 (2,686 bp) and purified human OSM exon 3 DNA fragments were 
electrophoresed on 1% (w/v) agarose while smaller human OSM exon 2 DNA 
fragments were resolved on 1.5% Synergel-0.7% agarose. The DNA molecules were 
recovered from gel by squeezing the gel slices with centrifugal force across a 3MM 
Whatman filter paper. The DNA suspension was then purified and extracted with 
chloroform and finally precipitated with ethanol and sodium acetate. 
Ligation reactions were carried out for exon 3 or exon 2 and Sma I cut pUC 18 
and Sma I cut pUC 18 alone. A 20-p,l reaction mixture containing appropriate amount 
of insert and vector or vector alone, lx ONE-PHOR-ALL buffer (lOOmM Tris-acetate, 
100mM magnesium acetate, 500mM potassium acetate), 17 U of T4 DNA ligase 
(Pharmacia Inc.) and l m M ATP was incubated at 16°C ovemight. After incubation, the 
ligation products were purified by chloroform extraction and ethanol precipitation. The 
pellets were then resuspended in 10 ^1 sterile water. 
c. Preparation of competent cell 
E. coli strain DH 5a were used for preparing competent cells. Single colony 
was picked from a freshly streaked LB agar plate and dispersed in 1 ml SOB medium 
by vortexing. The suspension was inoculated into an Erlenmeyer flask containing 30 
ml SOB medium which was then incubated at 37°C with moderate agitation until the 
cell density reached 4 x 10^ viable cells/ ml (OD 550= 0.4). The culture was chilled on 
ice for 15 min before centrifugation at 1000 g for 15 min at 4°C. The pellet was 
resuspended in RF 1 solution (1/3 x collected volume) and incubated on ice for 30 min. 
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Centrifugation step was repeated and this time the resulting pellet was resuspended in 
RF 2 solution (1/12.5 o f t h e original volume) which was later incubated on ice for 15 
min. Aliquots of the competent cells were then distributed into pre-chilled screw cap 
tubes and immediately flash freezed in liquid nitrogen. The tubes were stored at -70°C. 
d. Transformation 
150 [x\ of competent cells was added to each 10 ^il purified ligation product and 
mixed well. The tubes were incubated on ice for 60 min, followed by heat shock in a 
42°C water bath for 2 min and immediately another 1-min incubation on ice. 800 ^1 of 
LB medium was added and incubated at 37°C with moderate agitation for 60 min. 
Different volumes (50 ^il, 100 fil，200 ^il and rest) of the culture were then spreaded on 
LB agar plates supplemented with ampicillin (100 p,g/ml), X-gal and IPTG. The plates 
were incubated at 37°C ovemight. 
e. Screening of recombinants by PCR 
Thirty white colonies from each batch (exon 2 or exon 3 insert) appeared on 
LBAMP-X-gal-IPTG plates were picked by sterile tooth-picks and resuspended in 50 ^1 
water. Bacterial cells were heat lyzed by boiling for 10 min and quickly chilled on 
ice/OSFaCl. 20 p,l of the solution was subjected to PCR with conditions as described in 
cloning section {Section 2.3.2). The PCR products were analyzed by gel 
electrophoresis. 
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/ Screening ofrecombinants by restriction enzyme digestion 
i) Preparation of plasmids 
Several recombinant colonies (white in color and gave appropriate PCR 
products in previous section) were separately cultured in 30 ml LB medium at 37°C 
ovemight for plasmid DNA extraction. The bacterial cells were transferred to Corex 
tubes and centrifuged at 5,000 rpm for 10 min in a JA-20 rotor (Beckman). The pellets 
were resuspended in STET.1 solution and added with 4 mg oflysozyme (Sigma). After 
mixing, the solution was boiled for 60 seconds and immediately centrifuged at 15,000g 
at 4°C for an hour. The supernatant was then transferred to a new microcentrifuge tube 
and its volume was adjusted to 900 i^l with TE buffer. The solution was sequentially 
treated with 10 U RNase ONE (37�C, 1 hour) and 1 mg of proteinase K (50�C，30 min). 
For 1 ml ofsolution, 400 i^l PEG solution (30% PEG 8000, 1.8M NaCl) was added and 
the mixture was incubated on ice for 30 min. Pellets were recovered by centrifugation 
at 15,000g at 4 � C for 30 min and resuspended in 450 i^l water. 50 ^1 of CTAB solution 
(5�/^ CTAB in 0.4 M NaCl) was added to pellet DNA molecules by centrifugation for 
15 min at room temperature. The CTAB-pellets were washed with 1.2 M NaCl 
solution which were then re-precipitated out by centrifugation. The pellets at this stage 
were resuspended in 200 i^l water and finally precipitated with 0.5x volume of 7.5M 
NH4OAc and 2.5x volume of absolute ethanol. The resulting pellets were resuspended 
in 100 i^l TEoi buffer and stored at -20°C. The concentrations of plasmid were 
determined by spectrophotometric method in which 1 unit of OD260 corresponds to 50 
^ig/ml dsDNA. 
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ii) Double restriction enzymes digestion of pUC 18 
To test if the clones of vector carried the insert of interest, purified plasmids 
from above were simultaneously digested with EcoK I and Bam H L The cutting sites 
o f p U C 18 by these two restriction enzymes were shown in Figure 3.3. Approximately 
10 U of each enzyme was used to digest 1 jig of plasmid DNA in lx Multi-Core buffer 
(25mM Tris-acetate pH7.8, 100mM potassium acetate, lOmM magnesium acetate and 
l m M DTT) at 3 7 � C for an hour. The products of digestion were then separated on 
agarose gel. If pUC 18 contained the subcloned human OSM exon 2 or exon 3，there 
would be a band of � 1 4 0 bp or � 6 1 0 bp in length respectively, in addition to the band 
ofl inearized pUC 18 (~ 2.7kb). 
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Figure 3.3 Subcloning of exon fragment into vector and screening of recombinant by 
restriction enzyme digestion. Resultant cut fragments were analyzed by 
electrophoresis on agarose gel to check their respective sizes. 
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3.3.4 Verification of the clones of human OSM exons 2 and 3 by cycle 
sequencing 
The identity of the putative human OSM exons 2 and 3 subcloned into pUG 18 
was verified by sequencing the two DNA fragments. Cycle sequencing using dideoxy 
chain terminators was adopted in this experiment. The sequencing primer used was 
M13/pUC Forward 23-Base Sequencing Primer (Gibco/BRL). The sequencing process 
was done using dsDNA cycle sequencing kit purchased from Gibco/BRL. The reaction 
was initiated by mixing the following: 24 i^l water, 4.5 i^l 10x buffer (300mM Tris-HCl 
pH9.0, 50mM MgCl:, 300mM KC1, 0.5% (w/v) W-1), 1 ^il purified pUC 18 with 
putative exon 2 or exon 3 insert, 6 p.1 4mM sequencing primer and 0.5 ^il o f l . 2 5 U/ ^1 
Taq DNA polymerase. 
8 \x\ of the reaction mix was pipetted to 4 separate microcentrifuge tubes which 
contained 2 ^il of one of the four types of termination mix (2mM either of ddATP, 
ddCTP, ddGTP or ddTTP and 100 ^M ofeach dATP, dCTP, deaza-dGTP and dTTP). 
The tubes were then overlaid with mineral oil and subjected to a temperature profile of 
9 5 � C for 36 sec, 50�C for 36 sec and 72°C for 84 sec. The profile was repeated for 25 
times and followed by a temperature extension at 72°C for 10 min. 
10 p,l sequencing products of each sample was resolved by 6% urea-
polyacrylamide gel operated in a Pharmacia ALF DNA sequencer. The sequencing 
products were denatured at 95�C for 3 min and then chilled on ice before gel separation. 
The sequencing gel was run at 40°C of 34 W for 6 hours and the running buffer used 
was 0.6x TBE. The laser power was set to 3 mW. 
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The raw DNA sequences of putative human exon 2 and exon 3 were edited by 
Pharmacia ALF manager and the edited DNA sequences were compared against the 
GenBank nucleotide and protein databases via the NCBI BLAST Electronic-mail 
service. 
3.3.5 Purification of human OSM exons from plasmid for making probe 
Human OSM exons subcloned into pUC 18 were first excised and purified 
from the vector before probe making. pUC 18 carrying exon 2 and exon 3 were 
separately digested with both EcoR I and Bam H I in lx Multi-Core buffer, as described 
in Section 3.3.3f(ii). The products were resolved in 2% (w/v) agarose gel and the 
bands corresponding to exons 2 and 3 were cut out. The DNA fragments were then 
extracted and purified following the procedures depicted in Section 3.3.3 a (i). The 
quantity of recovered DNA was estimated by comparing the intensity of EtBr-stained 
bands with known amounts of the corresponding exon fragment. 
3.3.6 Southern blotting 
CL Probe making and labeling 
The probes of human OSM exon 2 and exon 3 were made and labeled by PCR 
method. The templates used were purified exon fragments excised from plasmid pUC 
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18. 32p-dCTP was incorporated into PCR using the same pair of specific primer used in 
P C R c loning {Section 3.2.8). 
The composition of a labeling reaction in a final volume of 50 p,l was 0.2 ng of 
template, 15mM Tris-HCl (pH 8.3), l x buffer, 0.25 U of ThermoprimeP'^ DNA 
polymerase, 1 | iM of each primer, 200 ^iM of each dATP, dCTP and dGTP, 3.2 ^iM 
dCTP and 0.8 ^iM ^^P-dCTP. The reaction was overlaid with mineral oil and was 
subjected to 30 cycles of amplification (94°C, 1 min; 56°C, 1 min; 72°C，lmin) 
following denaturation at 94°C for 2 min. 
After amplification, PCR products were separated from primers and 
unincorporated nucleotides through NICK column, Sephadex G50 (Pharmacia) 
following the procedures of its instruction manual. The percentage of incorporation of 
32p-dCTP therefore the yield o f P C R was estimated by scintillation counting of samples 
before and after NICK column separation. 
b, Preparation of mouse genomic DNAs 
The protocol for preparing genomic DNA was modified from Xu et aL, 1990. 
The spleens of mouse strains BALB/c and C57BL were dissected out and washed with 
PBS. Single cell suspension was made by passing through sterile stainless steel mesh. 
Cell pellets were obtained by centrifugation and resuspended in 0.5 ml PBS. The cell 
suspension was then added dropwise to a Petri dish containing 4 ml guanidinium 
thiocyanate (GT) solution (4M GT in O.lM Tris-HCl pH 7.5) and O.lM NaOAc with 
Chapter 3 Molecular analysis of mouse Oncostatin M 138 
gentle shaking. 2 ml of the cell lysate was then carefully layered under 10 ml of 
absolute ethanol (EtOH) in a 15-ml centrifuge tube using a large bore siliconized 
Pasteur pipette wetted with EtOH for transfer. The DNA was then recovered by rolling 
the tube horizontally until white threads of condensed nucleic acids were observed. 
The tube was further gently inverted several times to thoroughly mix the EtOH and 
aqueous phases and to pack the threads tightly. The DNA pellets were sequentially 
transferred to tubes of 70 % and 100% EtOH and finally dried in air. The DNA was 
then dissolved in 2 ml TE buffer with 2 % SDS and treated with 100 U RNase ONE 
(37�C，2 hours) and subsequently with 100 ^ig proteinase K (37�C，ovemight). The 
D N A was recovered as before by adding 10 ml EtOH. The pellet was finally 
resuspended in 2 ml T E � i buffer. Incubation at 65°C was generally needed to facilitate 
dissolution of pellets. 
Concentration and quality of genomic DNA were determined by 
spectrophotometric measurement and agarose gel electrophoresis. 
c, DNA transfer 
i) Digestion of genomic DNA with restriction endonucleases 
Large and complex genomic DNAs have to be digested by restriction enzyme 
into smaller fragments before blotted on membrane. 10 - 15 \xg of each type of 
genomic DNA was digested with restriction endonucleases, EcoK I，Hind III and Pst I. 
Digestion was carried out with 10 U of each restriction enzyme per ^ig DNA in lx 
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corresponding buffer and incubated at 37�C for at least 6 hours with occasional gentle 
mixing. The digestion mixture was then extracted with chloroform and concentrated 
into 30 ^il TEo.i buffer with ethanol precipitation. 
ii) Gel electrophoresis and DNA blotting 
The 30 p,l digested DNA and molecular size markers were loaded into 
performed well in 0.8 % (w/v) agarose gel and electrophoresed at 1 V/ cm of gel length 
in l x TAE buffer containing 0.5 fig/ml EtBr. The subsequent procedures of DNA 
transfer to nylon membrane was depicted in Section 2.3.6 a. 
d. Hybridization 
The baked nylon membrane with DNA was placed into a roller bottle. 50 ml of 
hybridization buffer {section 2.2.4) was added and prehybridization was performed for 
at least 4 hours at 68°C for human DNA blot and at 60�C for mouse DNA blots with 
constant rotation in a hybridization oven (Robbins Scientific Co.). 
After prehybridization, the solution was replaced by � 1 0 ml of hybridization 
buffer containing 5 - 10 ng/ml radiolabeled human OSM exon 2 or exon 3 fragments 
which were freshly heat denatured. Hybridization was carried out for 18 hours at 68°C 
and 24 hours at 60°C for human DNA blot and for mouse blots respectively. 
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Washing steps o fny lon membranes after hybridization were different for human 
D N A blot and mouse blots. They were listed as follows: 
Human OSM exon 3 Human OSM exon 3 
vs vs 
Human genomic DNA blot Mouse genomic DNA blot 
5XSSC; 0.1% SDS 2 X 15min at 60°C 
2XSSC; 0.1% SDS 2 X 15 min at RT 2XSSC; 0.1% SDS 2 x 15 min at 60°C 
O.lX SSC; 0.1% SDS 2 X 15 min at 68°C IX SSC; 0.1% SDS 2 x 15 min at 60°C 
Human OSM exon 2 
vs 
Mouse genomic DNA blots 
2X IX 0.5X O.lX 
5X“，2x 15min at 60°C 5X , 2xl5min at 60°C 5X，2xl5min at 60�C 5X，2xl5min at 60°C 
2X5，2xl5min at 60�C 2X, 2xl5min at 60�C 2X, 2xl5min at 60�C 2X, 2xl5min at 60�C 
IX", lxl5min at 60�C IX，lxl5min at 60�C IX，lxl5min at 60�C 
0.5X"，lxl5min at 60°C 0.5X, lxl5min at 60°C 
O.lXe, lxl5min at 60°C 
"5X SSC; 0.1%SDS '2X SSC; 0.1%SDS MXSSC; 0.1%SDS ' 0.5X SSC; 0.1%SDS 
^O.lXSSC; 0.1%SDS 
The background was checked by Mini-monitor (Mini-instruments Ltd., type 
5.10). If the count was over 10 counts per second, the membranes were washed for 
longer time until the background dropped below 5 counts per second. 
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The washed membranes were blotted briefly between 3MM paper and secured 
within Saran wrap. The membranes were then fixed onto a X-omatic cassette with an 
intensifying screen (Kodak) and exposed to X-ray film (Kodak, X-omatic AR) at -70°C 
for 24 hours. 
The X-ray films were developed manually following the procedures of 5 min in 
GBX X-ray developer and replenisher (Kodak), 1 min in running water, 5 min in fixer 
and replenisher (Kodak) and finally 15 min in running water. 
The molecular size ofhybridization signal on exposed X-ray film was estimated 
by measuring the distance between the sample-loading well and the signal. A standard 
curve was drawn by the molecular size of marker standards against the migration 
distance in a semi-log scale format. Molecular size of the signal was determined by 
interpolating its migration distance. 
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3.4 Results 
3.4.1 Cloning of human OSM exon 2 and exon 3 by PCR 
Human OSM exons 2 and 3 fragments were cloned by PCR method using 2 
separate pairs of primers. The PCR products were analyzed on Synergel-agarose gel 
(Figure 3.4). The sizes o f t h e amplified exon 2 and exon 3 fragments were 121 bp and 
591 bp respectively. 
3.4.2 Subcloning of human OSM exons 2 and 3 into pUC 18 
Purified PCR products of exon 2 and exon 3 were end-filled by T4 DNA 
polymerase to create blunt ends. The fragments were separately ligated to Sma I cut 
pUC 18. A control experiment which contained Sma I cut pUC 18 only was done in 
parallel. Bacterial colonies appeared on LB^^^-X-gal-IPTG plates were either white 
(recombinant) or blue (non-recombinant) in color. For the control experiment, all 
bacterial colonies were blue, indicating normal functioning of the lacZ gene. The 
transformation efficiencies for both exon 2-pUC 18 and exon 3-pUC 18 were over 90% 
as observed from the ratio of white to blue colonies. 
a. Screening of recombinants by PCR 
Identity of the recombinants were first checked by PCR. 30 white bacterial 
colonies from each batch (exon 2 or exon 3 insert) appeared on LB^^^-X-gal-IPTG 
^ 
!. i 
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plates were picked out and subjected to PCR and the products were electrophoresed on 
agarose gel (Figure 3.5). 
The product size should be either 591 bp or 121 bp if the recombinant bacteria 
truly carried the OSM exon fragments. For exon 3，20 out of 30 white colonies gave 
out a product fragment around 591 while for exon 2, the portion of true recombinant 
was rather low, just 7 out of 30. 
b. Screening ofrecombinants by restriction enzymes digestion 
Only those bacterial clones which carried appropriate exon fragments were 
further tested by restriction enzyme digestion. EcdK I and Bam H I cut at several bases 
away from the insertion site. Therefore, the digestion product should be a bit larger 
than the exon fragment. More exactly, the digestion product for exon 3 was 612 bp 
and that for exon 2 was 142 bp (Figure 3.6). 
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b p ^ ^ ^ ^ 2 ^ 
1,018 — B ^ B B ^ B B 
5 1 7 — m m m ^ < - 59ibp 
5 0 6 ; B M l 
3 9 6 ^ J J J U J 
2 0 1 ~ n m ^ n i m 
134 — H ^ ^ | ^ 121bp 
Figure 3.4 PCR products amplified by specific primers for human OSM exons 2 and 3. After 
30 cycles of amplification, the products were resolved on Synergel-agarose gel 
and stained with EtBr. Lane M: 1 kb DNA size marker; lane 1: exon 3 
fragment(591 bp); lane2: exon2 fragment(121 bp). 
Chapter 3 Molecular analysis of mouse Oncostatin M 145 
A 
M exon 2 clones 
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^ 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ j j ^ ^ m u n ^ ^ ^ j ^ j ‘ i 2 i b p 
B M exon 3 clones 
m i ^ H I ^ ^ ^ H B H H B 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ S ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 9 - ^ - 5 9 1 b p 
Figure 3.5 Screening of recombinants by PCR. Reaction was performed directly from 
bacterial colonies which were white in color on LB^^-X-gal-IPTG plate. 
Bacterial cells were heat lysed by boiling and subjected to 50-cycle PCR 
using the original pair of primer either specific to hOSM exon 2 or exon 3. 
Panel A: human OSM exon 2 clones; panel B: human OSM exon 3 clones. 
M: lkb DNA size marker. 
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M ^ 2 
bp 1 ^ — p U C 18 
• � j ^ ^ m n j j i 
1,018 — I ^ ^ ^ ^ ^ B I 
517 1 ^ " � 6 0 0 b P 
506 | ^ ^ ^ ^ ^ ^ | 
134 — f ^ ^ ^ ^ ^ l " ^ �140bp 
Figure 3.6 Double digestion of recombinant plasmids with EcoKl and Bam HI . 
Recombinant plasmids carrying human OSM exon 2 or 3 were digested 
with the two restriction enzymes. Lane 1: exon 3 clone. Digestion resulted 
ina fragment of 612bp and the vector pUC 18 fragment (2,665 bp). 
Lane 2: exon 2 clone. The cut fragment size was 142 bp in addition to the 
vector band. M: 1 kb DNA size marker. 
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3.4.3 Sequence ofsubcloned exons 2 and 3 
After being screened by PCR and restriction enzyme cutting, the identity o f t h e 
putative clones was verified by sequencing. The DNA sequences of the two subclones 
were compared against the Genbank nucleotide and protein databases via the NCBI 
BLAST Electronic-mail service. The sequences were found to be best fit to human 
OSM exon 2 and exon 3 fragment, the region flanked by the upper and lower primers. 
Alignment of putative clone sequences with exon 2 and exon 3 was done to check the 
similarity (Figure 3.7). The alignment test revealed that the PCR cloned human exon 2 
and 3 only had 4.35% and 5.74% dissimilarity from the published data respectively. 
This was most probably due to the errors generated during PCR reaction in which the 
fidelity of ThermoprimeP'^ DNA polymerase was concerned. Furthermore, error 
generated during DNA sequencing might have its contribution to the mismatch. In 
spite of the minor differences, it is reasonable to confirm the identities o f t h e subcloned 
fragments. Li other words, human OSM exons 2 and 3 were successfully cloned by 
PCR method using the two pairs of specially designed primer. The two verified clones 
were subsequently used to generate probes of human exon 2 and 3 fragments for 
hybridization. 
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Exon 2 
U 2 1 TCTGGTGCTTGCACTCTG..TTCCAAGCATGGCGAGCATGGC.GCTATAG 6 7 
M i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i m m 
L 8 TCTGGTCCTTGCACTCCTGTTTCCAAGCATGGCGAGCATG6CGGCTATAG 5 7 
• • 參 _ 參 
U 6 8 GCAGCTGCTTG.AAGAGTACCGCGTGCT.CTTGGCCAACTCCAGAAGCAG 1 1 5 
i i m i m I m i m m m m i i i i i i i i i i i i i i i i i i i i 
L 5 8 GCAGCTGCTCGAAAGAGTACCGCGTGCTCCTTGGCCAGCTCCAGAAGCAG 1 0 7 
• • 
U 1 1 6 ACAGATCTCATGCAGGACAC 1 3 5 
I I I I I I I I I I I I I I I I I I I I % Similarity: 95.65 
L 1 0 8 ACAGATCTCATGCAGGACAC 1 2 7 
Exon 3 
• • • 參 • 
U 1 5 CCAAGGCCTGGATGTTCCTAAACTGAGAGAGCACTGCAGGGAGCGCCC.. 6 2 
I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
L 1 5 CCAAGGCCTGGATGTTCCTAAACTGAGAGAGCACTGCAGGGAGCGCCCCG 6 4 
• 參 參 鲁 • 
U 6 3 GGGCCTT.CCCAGTGAGGAGA.CCTGAGGGG..CTGGCAGGCGGGG.TTC 1 0 7 
i i m i i i m m m m i i i i i i i i i i i i i i i i i i i i i i i 
L 6 5 GGGCCTTCCCCAGTGAGGAGACCCTGAGGGGGCTGGGCAGGCGGGGCTTC 1 1 4 
• • • • 鲁 
U 1 0 8 CTGAAGACCCTCAATGCCACACTGGGCTGCGTCCTGAACAGACTTGCCCG 1 5 7 
1丨丨 l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l II III 
L 1 1 5 CTGCAGACCCTCAATGCCACACTGGGCTGCGTCCTGCACAGAC.TGGCCG 1 6 3 
• • 參 • • 
U 1 5 8 ACTTAGAGCAGCGCCTCCCCAAGGCCCAGGATTTGGAGGAGGCTGGGCTG 2 0 7 
l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l I l l l l l l l l 
L 1 6 4 ACTTAGAGCAGCGCCTCCCCAAGGCCCAGGATTTGGAGAGGTCTGGGCTG 2 1 3 
• 
U 2 0 8 .ACATCCGAGCCTTGGAG 2 2 4 
l l l l l I l l l l l l l % Similarity: 94.26 
L 2 1 4 AACATCGAGGACTTGGAG 2 3 1 
Figure 3.7 Alignment of nucleotide sequences of subcloned PCR product and 
human OSM exon fragment. Upper (U) is the sequence of subcloned 
PCR product while lower (L) is the documented human OSM exon 
fragment. 
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3.4.4 Southern hybridization 
a. Genomic DNA preparation 
Human and mouse genomic DNA were purchased from company while those of 
BALB/c and C57BL were extracted from their spleens in our laboratory using Xu's 
protocol (1990). The concentration and yield of DNA were determined by 
spectrophotometric measurement and were listed in Table 3.2: 
Table 3.2 Extraction of genomic DNAs of BALB/c and C57BL mouse strains. 
BALB/c C57BL 
OD260 0.042 0.024 
OD280 0.023 0.012 
OD2e0 / OD280 1.857 1.974 
Concentration (^ig/^l) 0.42 0.24 
Yield (^ig DNA / spleen) 840 480 
Quality of the extracted DNA was checked by agarose gel electrophoresis 
(Figure 3.8). Most of the molecules were greater than 23 kb and RNA contamination 
was not detected in both cases. 
i. i • 1 
r 
I 
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• 棚 
^^B Wfpy^^^^^ -： ^ ^^KgSl^^BS(^^^^^^^SmS^Sl^^^ 
^^''Wi^i(fmmi& '"¾¾¾!! • 
Figure 3.8 Genomic DNA of BALB/c (lane B) and C57BL (lane C) resolved on 
1% agarose gel. LaneM is the Hind III cut lambda DNA whose largest 
DNA band is 23 kb in size. 
I 
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b. Digestion of genomic DNAs 
Large DNA molecules were digested by restriction enzymes before blotted on 
membrane for hybridization. Human and mouse DNA were cut by three restriction 
enzymes (JEcoR I, Hind III and Pst I) and the resultant products were resolved in 
agarose gel as shown in Figure 3.9. EcoR I，Hind III and Pst I chopped DNA into 
pieces with sizes ranged from several hundred base pairs to 30 kb which appeared as 
smears on gel during electrophoresis. Satellite DNA bands were observed in Hind III 
digested human DNA and EcoR I digested mouse DNA. It is worth to note that Hind 
III could not properly digest the mouse DNA molecules because of certain technical 
problems. Most of the DNA molecules were still greater than 30 kb in size after 
digestion and clumped together. 
In addition, four identical sets of blotting of EcoR I digested BALB/c and 
C57BL genomic DNA were also prepared for Southern hybridization against human 
OSM exon 2 fragment. Similarly, the products were resolved on agarose gel before 
blotting and the gel electrophoresis photo was presented in Figure 3.10. Satellite DNA 
bands were also observed in the digest. 
I： 
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^^^^HH^HHiHBHH^^^^^^^^^H^I^^^^^^^^^^H^^I ^ ^ ^ H ^ ^ B H H ^ ^ H g 
i 2 . i - f f W _ ^ B 
B 2 M I j J | ^ W a ^ | m H ^ ^ 
B i L ^ ^ H ' ^ f l _ 
B U J J I H M M ^ 
^^ ^^ ^^ ^^ |^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ n^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ H^ ^^ B^ ^^ ^^ |H 
1 m i i M i i M i i M i i i i i i i i i i M i i i M 
M " M i M M i M i i i M i i i i M i i M i i M M l i M i i i ^ 
^^ ^^ m^ ^^ ^^ m^ ^^ y^ ^^ ^^ i^ ^^ ^^ j^ Q^ ^^ j^ ^^ ^^ imi^ ^^ ^^ ^^ ^^ ^^ m^^ ^^ ^^ m 
M M B i l l M I M W — i — l ^ l 
H H H H H 
Figure 3.9 Electrophoresis of the restriction enzyme digested human and mouse genomic 
DNA. lOp,g of human and mouse genomic DNA were separately digested 
with EcoR I (lane E), Hind III (lane H), Pst I (lane P) and subsequently 
fractionated on 1% agarose gel. 
Panel A: human genomic DNA; panel B: mouse genomic DNA. 
Ml is 1 kb DNA ladder; M2 istheJ7wd III cutlambdaDNA. 
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kb ^ m m m i i m j j j n m m i m m 
12.1 - ^ g l ^ B ^ ^ ^ ^ B I W B l W r W ^ ^ ^ W B 
jftPflRHii I ^^I,'V^HH I i m I aH 
i H H ^ I H I ^ m H H H I H H B 
Figure 3.10 Electrophoresis of EcoRl digested mouse genomic DNA. Before transferred 
to nylon membrane, 4 sets of BALB/c (B) and C57BL (C) mouse genomic 
DNA were separately digested with EcoRl and fractionated on l%agarose 
gel. Each set of mouse DNA was accompanied with a size marker, 1 kb DNA 
ladder (lane M), on the left-hand-side. 
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c, Hybridization signal 
After digestion and fractionation on agarose gel, genomic DNAs were 
transferred to nylon membrane for hybridization. In the first trial, exon 2 fragment was 
used as probe against mouse genomic DNA. Four identical mouse DNA blots were 
prepared simultaneously in one blotting step. The four membranes were then subjected 
to same hybridization conditions but different stringency of washing, from 2X SSC up 
to O.lX SSC at 60°C. Hybridization signals were observed in only 2X and IX blots but 
not in 0.5X or O.lX blots as shown in Figure 3.11. Three DNA bands, which had 
migrated 3.9 cm, 4.9 and 5.3 cm were found in both mouse species, but an additional 
band which migrated 7.5 cm was detected in C57/Black. These DNA molecules binded 
with the probe, thus having homologous sequences. Their estimated sizes were 6.7 kb, 
5.0 kb, 4.5 kb and 2.4 kb respectively. Only the 6.7 kb fragment band was detected in 
IX blot. The band became faint as stringency of washing increased. 
Exon 3 fragment was then probed against both human and mouse genomic 
DNA but with different hybridization and washing stringency (referred to Section 3.3.6 
d). Hybridizing signals were observed in the human blot (Figure 3.12). EcoR I，Hind 
III and Pst I all gave a single positive band. Their molecule sizes were 5.1 kb, 6.7 kb 
and 4.3 kb respectively, as derived from their migration distances. 
As seen from Figure 3.13, positive signal in smears resulted when using human 
OSM exon 3 fragment as probe against mouse DNA. The situation did not improve 
even the washing stringency rised to IX SSC. 
I 
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Figure 3.11 Southern hybridization of mouse genomic DNAs against human OSM exon 2 
fragment. Four identical blots were prepared for different stringent washing 
conditions. The number in parenthesis indicates the lowest concentration of 
SSC used for washing that individual blot. The sizes of the signal bands were 
determined by measuring their migration distances and referring to a semi-log 
scale standard curve. LaneB: BALB/c DNA; C: C57BL DNA 
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Figure 3.12 Southem hybridization of human genomic DNA against human OSM exon 3 
fragment. Restriction enzyme digested human DNAs (as shown in Figure 3.9A) 
were blotted on membrane and hybridized with radioactively labeled hOSM 
exon 3 fragment. The hybridization was carried out at 68°C ovemight and the 
washing stringency was up to 0.1XSSC;0.1%SDS at 68°C. E: EcoR I digest 
gavea positive signal which corresponds to a fragment 5.1 kb in length; while 
H: Hind III digest and P: Pst I digest contained 6.7 kb and 4.3 kb fragments 
respectively, which are homologous to human OSM exon 3 sequence. 
I 
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[ Figure 3.13 Southern hybridization of mouse genomic DNA against human OSM exon 3 
fragment. Restriction enzyme digested mouse DNAs (as shown in Figure 3.9B) 
were blotted on membrane and hybridized with radioactively labeled hOSM 
exon 3 fragment. The hybridization was carried out at 60°C ovemight and the 
washing stringency was up to IX SSC; 0.1% SDS at 60°C. 
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3.5 Discussion 
3.5.1 Cross-species hybridization 
The aim of the second part of the project is to perform preliminary study of the 
not yet cloned mouse OSM gene so as to check the feasibility of using human OSM as 
probe for fishing out the mouse counterpart. There were examples of using this type of 
cross-species hybridization in cloning genes. For instance, human IL-5 gene was 
isolated using mouse IL-5 cDNA as probe (Campbell et aL, 1987). The homology 
between the coding region of the mouse and human IL-5 gene is found to be 74.9%. In 
another case, Dr Fung's group attempted to use murine IL-3 coding sequence as probe 
to isolate the corresponding human IL-3 gene (Dr M.C. Fung, personal 
communication). However, they failed to obtain the human clone because of the low 
sequence homology (45%) between the two coding regions (Dorssers et al., 1987). 
Yang et al. (1986), on the other side, could successfully isolate the human IL-3 gene by 
using gibbon IL-3 cDNA as probe. The success was due in large part to the significant 
homology between the gibbon and human IL-3 coding region (99.5%). 
3.5.2 Hybridization of human OSM exon fragments against mouse genome 
a. hOSM exon 2 as probe 
Four identical sets of EcdK I digested BALB/c and C57BL genomic DNA 
were blotted on membranes and subjected to hybridization with cloned hOSM exon 2 
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fragment as probe under the same condition. After hybridization, the four individual 
membranes were washed separately with different washing stringencies, ranging from 
2X SSC up to O.lX SSC at 60°C. A weak band corresponding to 6.7 kb could be 
clearly seen in the blots of 2X and IX SSC washing conditions. Two additional bands 
of 5.0 kb and 4.5 kb were observed in the 2X SSC washed blot. One more faint band 
corresponding to 2.4 kb DNA could be seen in C57/Black mouse strain. No 
hybridization signal was detected under high stringency washing (0.5X and O.lX SSC). 
In general, the washing conditions should be as stringent as possible. A 
combination of temperature and salt concentration should be determined empirically. 
In this exon 2 trial, immobilized mouse DNA was hybridized to human OSM exon 2 at 
60°C and then washed with buffers of different salt concentrations at 60�C. As the 
temperature was fixed, the stringency solely depended on the ionic strength which in 
tum affected the melting temperature (T^) of the hybrid formed between the probe and 
its target. T^ may be estimated from the following equation: 
T„ = 81.5�C + 16.6( logio[Na+]) + 0.41(%G+C) - (600//) (Maniatis et al., 1982) 
where 1 is the length of the hybrid in base pair and pSfa+] is the concentration of 
sodium ions in the final stringent wash solution. It should be noted that Tm of a double-
stranded DNA decreases by 1 - 1.5°C with every 1% drop in homology (Bonner et al., 
1973). 
As there are no positive signals found in 0.5 or O.lX SSC washing, the 
homology between human and mouse OSM gene is expected to be not high. 
广， 
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b. hOSM exon 3 as probe 
Human OSM exon 3 was also used as probe to perform a Southern 
hybridization against mouse genomic DNA. This time, human genomic DNA was 
included and done in parallel with the mouse blot but with different hybridization and 
washing conditions. As human gene exon to human genome, higher stringency of 
hybridization and washing was carried out for the human blot (hybridized and washed 
at 68°C and up to O.lX SSC washing). Single band was detected for EcoR I, Hin^ III 
and Pst I digested human DNA at the same time. 
For the mouse blot, washing was carried out with IX SSC at 60°C. In contrast 
to the result of using hOSM exon 2 as probe, smears of signal was observed. Such non-
specific binding is most likely due to the high G-C content of the hOSM exon 3. The 
probe used here was the coding region of hOSM exon 3 which contains 65.25% of G 
and C bases. 
c. Feasibility of using hOSM as probe for fishing out the mOSM gene 
As viewed from the result of using hOSM exon 2 as probe, a corresponding 
mouse OSM gene was detected. It is therefore possible to isolate the mouse OSM gene 
using the human OSM cDNA as probe. However, the percentage ofhomology between 
two species OSM gene is quite low, thus rendering the process difficult. 
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Furthermore, the probe should be selected at a region of lower G-C content so 
as to avoid non-specific binding during hybridization. Therefore, hOSM exon 3 coding 
region that has high G-C content could not be used as probe for this purpose. 
d. The cloning of mouse OSMby Yoshimura，s group 
Nevertheless, the murine homologue of OSM has been successfully cloned by 
Yoshimura 's group lately (1996). Their approach of cloning mOSM did not employ 
cross-species hybridization but a cDNA library subtraction procedure. Since OSM has 
been identified as a cytokine-inducible immediate early gene through the JAK-STAT5 
signaling pathway, mOSM clone was screened out from a subtracted cDNA library in 
which JAK-STAT5 inducible genes were enriched. The full-length mOSM cDNA was 
sequenced and the intron-exon structure was also determined. The human and mouse 
clones are similar in their gene structure, that is three exons with two intervening 
introns which are found at identical sites (Yoshimura et al., 1996). 
By comparing the sequence of human (Malik et al., 1989) and mouse 
(Yoshimura et al.,l996) OSM exon 2，the homology is found to be very low (only 
28.16%) within this region. This finding confirms the prediction inferred from the 
result of the present study. 
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Chapter 4 
Conclusion 
4.1 Summary of cytokine and cytokine receptor genes expression 
during embryonic development 
In this part of the project, the expression pattem of 30 cytokines and cytokine 
receptors over the course of embryonal development in mouse was examined. The 
results clearly showed that the expression of these molecules were developmentally 
regulated. Two important points can be drawn from the above observations. 
The first point is that the subset of cytokines controlling hematopoiesis in adult 
is different from those functioning in embryo. Most hematopoietic cytokines were 
absent from those embryonic tissues studied in this project, like IL - l a , IL-2, IL-3, IL4, 
IL-5, IL-6, G-CSF and GM-CSF. Among which, IL-3, G-CSF and GM-CSF were the 
most characterized factors in adult hematopoiesis, however, they did not express in 
mouse embryos at all. Therefore, it could be concluded that these 3 factors were not 
critical to fetal hematopoiesis or development. This point was supported by the 
observations in the studies of Rappolee et aL (1988)，Schmitt et aL (1991) and Kohchi 
et aL (1994). Only the transcripts o f I L - i p , SCF, M-CSF and LIF upon the group were 
detected in embryos. This observation indicates that the pool of cytokines being 
effective in adult is much bigger than that in fetus. The absence of a number of 
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cytokines in developing embryos can be explained in two ways which were 
schematically represented in Figure 4.1. 
The first explanation is the pleiotropy and redundancy in biological actions of 
cytokines. Each cytokine exhibits a wide variety of activities and each activity is 
exhibited by a wide variety of cytokines. The physiological functions of a particular 
cytokine can be substituted by its surrogates (Figure 4.1a). Indeed, the emerging 
picture in both haematopoietic and embryonic development is one in which the 
behavior of a stem is not exclusively regulated by a unique factor, but rather is 
governed by the interplay of several cytokines. 
(a) (b) 
SCF 
LIF Adul t E m b r y o 
I L - l p K j | 
M - C S F ； \ y ^ 
P ^ OR \ ^ i 
IL-3 ^ ^ ^ 9 C 
G - C S F L ^ ^ H ^ l _ Z J 
G M - C S F 
Figure 4.1 Two hypotheses explain why major hematopoietic cytokines were not 
found in mouse embryos. 
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An alternative explanation for the smaller pool of cytokines observed in mouse 
embryo is that there are actually many other factors that have not been discovered yet. 
These unknown factors may specially control hematopoiesis in embryo, substituting for 
those cytokines claimed to be important in adult hematopoiesis but absent in embryos. 
In other words, the subset of cytokines controlling hematopoiesis in adult and in 
embryos are different with certain overlapping (Figure 4.1b). However, further 
investigation and much more efforts are required to support this hypothesis. 
The second point as concluded from the results of the present study is that 
cytokine receptors can be present even in the absence of their corresponding cytokines. 
For instance, the transcripts of IL-2Ra, IL-3R(AIC2A) and IL-3R(AIC2B) were 
detected in all the embryo tissues even though IL-2 and IL-3 were not found in those 
samples. The biological significance of such phenomenon remains unclear but there 
are two speculations. One is that expression of cytokine receptors on target cells 
always precede their corresponding factor. This serves to prepare target cells at a ready 
state to be responsive to cytokines once they are produced. Schmitt and co-workers 
(1991)，using murine ES cell system, detected the expression of various cytokines and 
cytokine receptors in differentiated ES cells over 28 days. In most cases, the receptor 
genes were found to be transcribed before the corresponding cytokines. Another 
speculation is that the expression of receptors is actually for the binding to certain 
undiscovered ligands. However, such putative ligands still await our exploration in the 
future. 
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4.2 Further studies of the cytokine actions on embryogenesis 
The number of cytokines studied in this project is not sufficient to cover the 
enormous cytokine network. With primers specific to more other cytokines, the 
temporal pattem of their expression during embryonic development can be checked 
with this method. Since cytokines exert their actions through the interaction with 
specific receptors on target cells, the presence of cytokine will not necessarily 
guarantee an effect. Therefore, the expression pattem of their respective receptors have 
to be determined as well. 
It is noteworthy that the technique RT-PCR only provides a readout of mRNAs 
being produced by cells at a given point in time. However, transcription of gene does 
not always correspond qualitatively or quantitatively to translation. Due to this reason, 
further experimentation is required to determine whether transcripts are indeed 
translated and bring about their biological effects. Two approaches have generally been 
used to detect the production of cytokine proteins; they are either an immunological 
assay using growth-factor-specific antibodies or a bioassay selected for sensitivity to a 
particular cytokine present in the medium conditioned by producing cells or in cell 
extracts. 
A direct way to reveal the exact function of a cytokine in development is to 
interrupt its gene expression. This can be achieved by targeted mutagenesis using 
homologous recombination to disrupt the cytokine gene in ES cells. Such ‘knockout 
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mice，model provides a means of understanding the pathophysiological consequences 
of the loss of a cytokine, from which the in vivo functions of that cytokine can be 
inferred. 
It will be of interest to find out whether cytokines in other mammals, like 
human, share the same properties. If so, cytokines will not only provide a means to 
control pregnancy, but it may also help to improve the establishment of successful 
pregnancies from embryos produced by in vitro fertilization. 
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4.3 Molecular analysis of mouse OSM gene 
As viewed from the result of using hOSM exon 2 as probe, a corresponding 
homologue was detected in the mouse genome. However, the signal was weak and 
could hardly be seen in high stringency washing. The degree of homology was 
therefore predicted to be very low. 
Using hOSM exon 3 coding region as probe against mouse genomic DNA had 
resulted into much non-specific bindings, probably due to high G-C content within the 
region. As concluded from these observations, it will be technically impossible to 
clone the mouse OSM gene using cross-species hybridization. 
The cloning of murine OSM gene will certainly foster the understanding of th i s 
cytokine using the mouse model. With mOSM sequence being revealed, specific 
primers can then be designed and its expression profile during embryogenesis can be 
determined in the same manner as described in this study. It is expected in the near 
future that the creation of mice lacking the OSM gene will provide a clear insight into 
the physiological function of this cytokine. 
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